<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Linear polysialoside outperforms dendritic analogs for inhibition of influenza virus infection in vitro and in vivo</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Sumati</forename><surname>Bhatia</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institut für Chemie und Biochemie Organische Chemie</orgName>
								<orgName type="institution">Freie Universität Berlin</orgName>
								<address>
									<addrLine>Takustr. 3</addrLine>
									<postCode>14195</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Daniel</forename><surname>Lauster</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Institut für Biologie</orgName>
								<orgName type="department" key="dep2">Molekulare Biophysik</orgName>
								<orgName type="institution">IRI Life Sciences</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Humboldt-Universität zu Berlin</orgName>
								<address>
									<addrLine>Invalidenstr. 42</addrLine>
									<postCode>10115</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution" key="instit1">Experimentelle Rheumatologie</orgName>
								<orgName type="institution" key="instit2">Deutsches Rheuma-Forschungszentrum Berlin</orgName>
								<orgName type="institution" key="instit3">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Charitéplatz 1</addrLine>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="laboratory">Unit 17, Influenza and other Respiratory Viruses</orgName>
								<orgName type="institution">Robert Koch-Institut</orgName>
								<address>
									<addrLine>Nordufer 2</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Markus</forename><surname>Bardua</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institut für Chemie und Biochemie Organische Chemie</orgName>
								<orgName type="institution">Freie Universität Berlin</orgName>
								<address>
									<addrLine>Takustr. 3</addrLine>
									<postCode>14195</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Institut für Biologie</orgName>
								<orgName type="department" key="dep2">Molekulare Biophysik</orgName>
								<orgName type="institution">IRI Life Sciences</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Humboldt-Universität zu Berlin</orgName>
								<address>
									<addrLine>Invalidenstr. 42</addrLine>
									<postCode>10115</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution" key="instit1">Experimentelle Rheumatologie</orgName>
								<orgName type="institution" key="instit2">Deutsches Rheuma-Forschungszentrum Berlin</orgName>
								<orgName type="institution" key="instit3">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Charitéplatz 1</addrLine>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Forschungszentrum für Elektronenmikroskopie and Core Facility BioSupraMol</orgName>
								<orgName type="department" key="dep2">Institut für Chemie und Biochemie</orgName>
								<orgName type="institution">Freie Universität Berlin</orgName>
								<address>
									<addrLine>Fabeckstr. 36a</addrLine>
									<postCode>14195</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="laboratory">Unit 17, Influenza and other Respiratory Viruses</orgName>
								<orgName type="institution">Robert Koch-Institut</orgName>
								<address>
									<addrLine>Nordufer 2</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kai</forename><surname>Ludwig</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institut für Chemie und Biochemie Organische Chemie</orgName>
								<orgName type="institution">Freie Universität Berlin</orgName>
								<address>
									<addrLine>Takustr. 3</addrLine>
									<postCode>14195</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Institut für Biologie</orgName>
								<orgName type="department" key="dep2">Molekulare Biophysik</orgName>
								<orgName type="institution">IRI Life Sciences</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Humboldt-Universität zu Berlin</orgName>
								<address>
									<addrLine>Invalidenstr. 42</addrLine>
									<postCode>10115</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution" key="instit1">Experimentelle Rheumatologie</orgName>
								<orgName type="institution" key="instit2">Deutsches Rheuma-Forschungszentrum Berlin</orgName>
								<orgName type="institution" key="instit3">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Charitéplatz 1</addrLine>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Forschungszentrum für Elektronenmikroskopie and Core Facility BioSupraMol</orgName>
								<orgName type="department" key="dep2">Institut für Chemie und Biochemie</orgName>
								<orgName type="institution">Freie Universität Berlin</orgName>
								<address>
									<addrLine>Fabeckstr. 36a</addrLine>
									<postCode>14195</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Materials</orgName>
								<orgName type="institution">Imperial College London</orgName>
								<address>
									<addrLine>Prince Consort Road</addrLine>
									<postCode>SW7 2AZ</postCode>
									<settlement>London</settlement>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="laboratory">Unit 17, Influenza and other Respiratory Viruses</orgName>
								<orgName type="institution">Robert Koch-Institut</orgName>
								<address>
									<addrLine>Nordufer 2</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefano</forename><surname>Angioletti-Uberti</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Nicole</forename><surname>Popp</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ute</forename><surname>Hoffmann</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Florian</forename><surname>Paulus</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Matthias</forename><surname>Budt</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Marlena</forename><surname>Stadtmüller</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Thorsten</forename><surname>Wolff</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alf</forename><surname>Hamann</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Christoph</forename><surname>Böttcher</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Herrmann</surname></persName>
						</author>
						<author role="corresp">
							<persName><forename type="first">Rainer</forename><surname>Haag</surname></persName>
							<email>haag@zedat.fu-berlin.de</email>
						</author>
						<author>
							<persName><forename type="first">Angioletti-Uberti S</forename><surname>Popp</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Stefano</forename><surname>Angioletti- Uberti</surname></persName>
						</author>
						<title level="a" type="main">Linear polysialoside outperforms dendritic analogs for inhibition of influenza virus infection in vitro and in vivo</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">3F5559EA5184C0FBF053A32307E286AE</idno>
					<idno type="DOI">10.1016/j.biomaterials.2017.05.028</idno>
					<note type="submission">Received Date: 19 March 2017 Revised Date: 17 May 2017 Accepted Date: 18 May 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:09+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>multivalent inhibitor</term>
					<term>influenza virus</term>
					<term>polyglycerol scaffolds</term>
					<term>ligand density</term>
					<term>steric shielding</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Inhibition of influenza A virus infection by multivalent sialic acid inhibitors</head><p><s>preventing viral hemagglutinin binding to host cells of the respiratory tract is a promising strategy.</s><s>However, optimal geometry and optimal ligand presentation on multivalent scaffolds for efficient inhibition both in vitro and in vivo application are still unclear.</s><s>Here, by comparing linear and dendritic polyglycerol sialosides (LPGSA and dPGSA) we identified architectural requirements and optimal ligand densities for an efficient multivalent inhibitor of influenza virus A/X31/1 (H3N2).</s><s>Due to its large volume, the LPGSA at optimal ligand density sterically shielded the virus significantly better than the dendritic analog.</s><s>A statistical mechanics model rationalizes the relevance of ligand density, morphology, and the size of multivalent scaffolds for the potential to inhibit virus-cell binding.</s><s>Optimized LPGSA inhibited virus infection at IC 50 in the low nanomolar nanoparticle concentration range and also showed potent antiviral activity against two avian influenza strains A/Mallard/439/2004 (H3N2) and A/turkey/Italy/472/1999 (H7N1) post infection.</s><s>In vivo application of inhibitors clearly confirmed the higher inhibition potential of linear multivalent scaffolds to prevent infection.</s><s>The optimized LPGSA did not show any acute toxicity, and was much more potent than the neuraminidase inhibitor oseltamivir carboxylate in vivo.</s><s>Combined application of the LPGSA and oseltamivir carboxylate revealed a synergistic inhibitory effect and successfully prevented influenza virus infection in mice.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Seasonal influenza A infections cause ~500,000 deaths and 3-5 million cases of severe illness annually worldwide <ref type="bibr">[1,</ref><ref type="bibr">2]</ref>.</s><s>The high mutation frequency of viral proteins limits both the use of vaccination <ref type="bibr">[3]</ref> and of approved therapeutics against viral proteins that mediate uncoating (e.g.</s><s>amantadine) or release (e.g.</s><s>oseltamivir) of the virus <ref type="bibr">[4]</ref>.</s><s>However, new approaches targeting conserved domains of the major viral spike protein hemagglutinin (HA) are still of great interest, since HA is required for early steps of the infection: binding to the sialic acid (SA) residues on the cell surface, and upon endocytosis, fusion with the endosomal membrane <ref type="bibr">[5]</ref>.</s><s>Recent developments of antibodies binding to the stem domain or to the SA binding pocket of HA are promising candidates with a broad spectrum activity <ref type="bibr">[6,</ref><ref type="bibr">7]</ref>.</s></p><p><s>Mimicking the host cell surface by multivalent presentation of SA residues on suitable polymeric scaffolds is an alternative to prevent infection by inhibiting the virus binding <ref type="bibr">[8]</ref><ref type="bibr">[9]</ref><ref type="bibr">[10]</ref><ref type="bibr" target="#b20">[11]</ref><ref type="bibr" target="#b21">[12]</ref>.</s><s>E.g., linear sialylated polyacrylamides (PAA) have been shown to efficiently compete for virus binding to the host cells <ref type="bibr">[8]</ref>.</s><s>However, typically they are cytotoxic <ref type="bibr" target="#b23">[13]</ref>, and of low biocompatibility <ref type="bibr" target="#b25">[14]</ref>.</s><s>Only a few sialylated multivalent inhibitors of influenza virus have been tested in vivo, however, without any promising perspective for application <ref type="bibr" target="#b26">[15,</ref><ref type="bibr" target="#b28">16]</ref>.</s></p><p><s>Major concerns are the geometrical requirements for multivalent ligand presentation optimal for in vivo application.</s><s>Dendritic scaffolds can present a rather structurally defined set of ligands compared to its linear more flexible counterparts.</s><s>In contrast, depending on their properties carbohydrate-conjugated linear polymers may offer a highly hydrated water swollen coiled scaffold with enhanced steric shielding properties in comparison to those of dendritic scaffolds.</s><s>Likewise, the optimal ligand density varies depending on the architecture type <ref type="bibr" target="#b30">[17]</ref>.</s><s>The importance of optimal ligand density has been addressed recently using spherical 6'-sialyllactose-PAMAM conjugates for efficient influenza virus inhibition <ref type="bibr" target="#b31">[18]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D</head><note type="other">ACCEPTED MANUSCRIPT 4</note><p><s>Finally, a low molecular weight of the polymer (&lt;40 kDa) for systemic clearance and a low toxicity are required for in vivo use <ref type="bibr" target="#b32">[19]</ref>.</s></p><p><s>Given the significance of scaffold geometries for contributions of steric shielding to inhibition of virus binding, a preference for linear or dendritic polymeric scaffolds is not a priori given <ref type="bibr" target="#b30">[17]</ref>.</s><s>We have now undertaken a systematic study on a series of linear and dendritic polyglycerols (LPG and dPG) with a similar linker strategy.</s><s>Due to its low toxicity and good in vivo clearance, PGs are a promising scaffold for a multivalent ligand display <ref type="bibr" target="#b33">[20]</ref><ref type="bibr" target="#b34">[21]</ref><ref type="bibr" target="#b35">[22]</ref>.</s><s>Setting the hypothetical models by Whitesides and coworkers <ref type="bibr" target="#b36">[23]</ref> on a quantitative basis, our recent studies have emphasized that apart from multivalent interaction size dependent steric shielding is indeed a key factor <ref type="bibr" target="#b37">[24]</ref>.</s><s>Hence, both affinity as well as steric shielding determine the efficacy of a multivalent inhibitor to block virus particles.</s><s>The highly water soluble SA-conjugated linear PGs possess a dynamic scaffold structure due to their flexibility amplifying steric shielding effects, as suggested by theoretical considerations showing that the linear scaffolds inhibit virus binding more efficiently than the dendritic scaffolds.</s><s>Taken together, we here present the design and synthesis of a non-toxic, low molecular weight multivalent inhibitor for influenza A virus that displays promising antiviral efficacy in vivo.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthesis and characterization</head><p><s>All reagents and solvents were purchased from commercial suppliers and used without further purification.</s><s>Reactions requiring dry or oxygen-free conditions were carried out under argon in Schlenk glassware. 1</s><s>H spectra were recorded on Bruker AMX 500 (500 MHz) and Delta Joel Eclipse 700 (700 MHz) spectrometer at 25 o C and calibrated by using the deuterated solvent peak.</s><s>Infrared (IR) spectra were recorded with a Nicolet AVATAR 320 FT-IR 5 SXC (Thermo Fisher Scientific, Waltham, MA, USA) with a DTGS detector from 4000 to 650 cm −1 .</s><s>A TSQ 7000 (Finnigan Mat) instrument was used for ESI measurements and a JEOL JMS-SX-102A spectrometer was used for the high-resolution mass spectra.</s></p><p><s>Molecular weight distributions of LPG 10 1, dPG 10 2, and the post functionalized polymers were determined by means of GPC coupled to a refractive index detector (RI) for obtaining the complete distribution (Mn, Mp, Mw, dispersity).</s><s>Measurements were carried out under highly diluted conditions (5 mg/ml) from a GPC consisting of an Agilent 1100 solvent delivery system with pump, manual injector, and an Agilent differential refractometer.</s><s>Three 30 cm columns (PPS: Polymer Standards Service GmbH, Germany; Suprema 100 Å, 1000 Å, 3000 Å with 5 and 10 µm particle size) were used to separate aqueous polymer samples using water with 0.1 N NaNO 3 as the mobile phase at a flow rate of 1 ml/min.</s><s>The columns were operated at room temperature (rt) with the RI detector at 50 °C.</s><s>The calibration was performed by using certified standards pullulan (linear) and dextran (branched) from PSS.</s></p><p><s>WinGPC Unity from PSS was used for data acquirement and interpretation.</s><s>The molecular weight of the dPG 500 3 was determined by gel permeation chromatography (GPC) using a DAWN-EOS multi-angle laser light scattering (MALLS) (Wyatt technology Inc., Santa Barbara CA) and optilab RI detectors; the details have been described previously <ref type="bibr" target="#b39">[25]</ref>.</s><s>An aqueous 0.1 N NaNO 3 solution (pH = 7.0) was used as the mobile phase and dn/dc value for PG used for the molecular weight calculation was 0.12 ml/g <ref type="bibr" target="#b40">[26]</ref>.</s><s>DLS measurements of the various polymers were conducted by using a NanoDLS particle sizer (Brookhaven Instruments Corp.) at 25 o C. Aqueous samples were filtered through 0.2 mm filters prior to analysis.</s><s>Water of Millipore quality was used in all experiments.</s><s>An USHIO super high mercury lamp (USH 102d, 100 W) was used for UV assisted thiol-ene click reaction.</s></p><p><s>Naturally occurring sialic acids constitute a family of more than 50 structurally distinct nine-</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT</head><p><s>6 carbon 3-deoxy-ulosonic acids, the most widespread derivative being 5-N-acetyl-neuraminic acid (Neu5Ac).</s><s>We used the abbreviation of sialic acid (SA) for Neu5Ac.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Virus material</head><p><s>X31 virus (influenza strain A/Aichi/2/68 H3N2, reassorted with internal segments of A/PuertoRico/8/1934 H1N1), A/Mallard/439/2004 (H3N2) or A/turkey/Italy/472/1999 (H7N1) were harvested from allantoic fluid of embryonated chicken eggs.</s><s>Virus isolates were clarified upon low speed centrifugation (300 x g, 10 min).</s><s>For binding (inhibition) experiments clarified allantoic fluid was further concentrated by ultracentrifugation (100,000</s></p><p><s>x g, 1 h).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture</head><p><s>MDCK-II (Madin-Darby canine kidney epithelial) cells (ATCC) have been maintained in DMEM (supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 µg/ml streptomycin and 100 units/ml penicillin) at 37 °C and 5% CO 2 .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hemagglutination inhibition assay (HAI)</head><p><s>Inhibitors were twofold serially diluted in PBS.</s><s>Then, 4 HAU X31 virus containing approximately 4•10 7 virus particles were added to all the wells.</s><s>The amount of virus particles per volume was estimated as published by Desselberger et al. <ref type="bibr" target="#b41">[27]</ref>.</s><s>After 30 min incubation under slight agitation at rt, 50 µl of a 1 % human erythrocyte solution (German Red Cross, ~2•10 6 cells/µl) was added, gently mixed, and incubated for 60 min at rt.</s><s>The inhibitor constant K i(HAI) , reflects the lowest inhibitor concentration, which is necessary to achieve full inhibition of virus induced hemagglutination.</s><s>To check for full hemagglutination inhibition, the microtiter plate was tilted by 60° to cause droplet formation from the red blood cell pellet <ref type="bibr" target="#b42">[28]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Erythrocyte binding inhibition assay</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D</head><note type="other">ACCEPTED MANUSCRIPT 7</note><p><s>Experiments were performed as previously described <ref type="bibr" target="#b43">[29]</ref>.</s><s>Briefly, influenza A virus (X31)</s></p><p><s>was labelled with 20 µM octadecylrhodamine B chloride (R18) in PBS and the free dye was removed upon virus pelleting.</s><s>5 µg labelled virus was incubated with two-fold serial dilutions of binding inhibitors, and incubated for 30 min at rt (0.5 µg/µl X31, ≈ 16 HAU/µl).</s><s>The</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Microscale thermophoresis</head><p><s>Measurements have been performed using a Monolith NT.115 instrument (Nanotemper) and standard glass capillaries.</s><s>For safety reasons X31 was inactivated with UV light for 5 min on ice.</s><s>Then the envelope of viruses (1 mg/ml protein) was labelled at 20 µM R18 for 30 min at rt under gentle shaking.</s><s>Unbound R18 was removed under centrifugation at 20,000 x g for 5 min.</s><s>The resuspended virus was filtered through a 0.45 µm filter (Millipore).</s><s>To quantify the amount of virus, and to check whether the prepared virus was still able to bind, a hemagglutination assay was performed.</s><s>Each inhibitor was twofold serially diluted and mixed with equal amounts of X31 (4 HAU) for 15 min at rt.</s><s>Then the inhibitor-virus mix was loaded on glass capillaries and measured at rt for initial fluorescence (5 s) and change in fluorescence over time <ref type="bibr">(30 s)</ref> with the thermophoresis measurement (MST power: 80%, green LED power 100%).</s><s>The T-jump with thermophoresis was used for analysis and gated</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Infection inhibition assay</head><p><s>Viral infection inhibition assays were monitored using a Cell Titer 96 Aqueous One Solution Assay (Promega) according to the standard protocol of the manufacturer.</s><s>The soluble 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromid salt (MTS) undergoes a colorimetric change upon reduction at active mitochondrial membranes to formazan (Abs.</s><s>490 nm).</s><s>Being proportional to the number of cells, mitochondrial activity can be monitored by this assay.</s></p><p><s>Cells infected with Influenza A virus cause a cytopathic effect, which goes along with reduced number of cells or cell viability, respectively.</s></p><p><s>Here, 15,000 MDCK II cells were seeded one day before infection.</s><s>On the day of infection, X31 were pretreated with sialosides in a twofold dilution series for 30 min at rt under slight agitation.</s><s>Net, cells were washed once with PBS ++ (containing 0.5 mM MgCl and 0.9 mM CaCl), and pretreated virus (MOI 0.05) was added for 1 h at rt to allow binding.</s><s>Unbound virus was removed by washing once with 37 °C infection medium (DMEM, 2 mM glutamine, 0.1% FCS, 0.1% BSA, 2.5 µg/ml TPCK-treated trypsin, Pen/Strep), and subsequently incubated for 24 h at 37 °C.</s><s>Following, 20 µl MTS solution was added to each well and incubated for 1 h at 37 °C.</s><s>Finally, absorbance at 490 nm was measured and data were normalized to maximum viral cytopathogenicity.</s></p><formula xml:id="formula_0">‫݈݈݁ܥ‬ ‫ݕݐ݈ܾ݅݅ܽ݅ݒ‬ ሺ%ሻ = ‫݀݁ݐ݂ܿ݁݊ܫ‪ሺ‬‬ ௧௧ௗ − ‫݀݁ݐ݂ܿ݁݊ܫ‬ ௨௧௧ௗ ሻ ሺܷ݂݊݅݊݁ܿ‫݀݁ݐ‬ ௨௧௧ௗ − ‫݀݁ݐ݂ܿ݁݊ܫ‬ ௨௧௧ௗ ሻ M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 9</formula><p><s>Dose response curves of mean values (n≥3) were fitted using a four parametric logistic fit to obtain IC 50 values.</s><s>The asymmetric standard error (SE) of the fit is given as logIC 50 .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Viral nucleoprotein expression analysis</head><p><s>X31 virus was pretreated in an inhibitor titration experiment with PGs and maintained for 30 min at rt.</s><s>The day before, 5x10 4 MDCK-II cells were seeded in an 8-well plate (ibidi).</s><s>On the following day, the cells were washed once with PBS ++ and infected with inhibitor or PBS treated X31 (MOI 0.1) for 1 hour on ice to synchronize the infection.</s><s>Unbound virus was removed by aspiration of the supernatant and subsequent washing with infection media (DMEM, 0.1% FCS, 0.1% BSA).</s><s>Following that, cells were incubated for 24 h at 37°C and analyzed for viral nucleoprotein expression by immunostaining as follows:</s></p><p><s>Cells were washed, fixed with 4% paraformaldehyde and permeabilized with 0.5% (w/v) triton X-100.</s><s>Furthermore, the cells were blocked with blocking buffer (PBS ++ , supplemented with 3% BSA and 100 mM glycine) for 2 hours at rt. Immunostaining was performed with an FITC coupled mouse α-NP monoclonal antibody (Millipore, 1:500 in PBS ++ with 1 % BSA) by incubating overnight at 4°C.</s><s>Cellular DNA was stained using DAPI.</s><s>Confocal microscopy was assessed using an Olympus FV 1000 microscope.</s><s>Acquired images were analyzed for viral NP expression using an ImageJ software as follows: Cells were automatically identified by an ImageJ script from the DAPI signal of the stained nuclei.</s><s>Each object representing one cell was further analyzed for the fluorescence intensity coming from the FITC coupled α-NP monoclonal antibody.</s><s>Median fluorescence intensities of all detected objects (n&gt;1000) were expressed in ratio to the infected, PBS-treated cells.</s><s>Statistics were performed using a one way ANOVA analysis with a Dunnett's multiple comparison test to the infected, PBS treated control.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Inhibition of multicyclic viral replication</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT</head><p><s>10 MDCK-II cells were infected with IAV X/31 at a multiplicity of 0.01.</s><s>After removal of the input virus, the cells were incubated in infection medium complemented with different concentrations of LPG 10 SA 0.40 1b or LPG 10 1 for 24 hours.</s><s>Virus titers in the supernatants were then determined by plaque titration on MDCK-II cells and are expressed as plaque forming units per ml (pfu/ml).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In vivo infection inhibition study</head><p><s>Animals were maintained and handled according to the Directive 86/609/EEC of the European Community Council and to the institutional, state and federal guidelines.</s><s>All animal protocols were approved by the ethics committee of the Landesamt für Gesundheit und Soziales (LAGeSo, Berlin, Germany) with registration number GG0011-15.</s><s>Animals were housed under standard conditions of 12-h light/dark cycle and given access to food and water ad libitum.</s><s>Experiments were performed with 8 weeks old BALB/c mice (Charles River) as previously described <ref type="bibr" target="#b45">[30]</ref>.</s><s>First, mice were sedated by an intraperitoneal injection of 200 µl Cepetor (4µg/100 µl) and anesthetized by isofluran inhalation.</s><s>Then, X31 virus was preincubated with inhibitor for 30 minutes at rt in PBS ++ before the 25 µl virus-inhibitor mix was distributed to both nostrils.</s><s>After complete uptake of the virus-inhibitor solution, mice were revitalized, by injecting 200 µl antisedan (2 µg/100 µl) intraperitoneally.</s><s>Groups of five mice were maintained per cage and experiment for 11 days.</s><s>The mice were weighed daily and the influenza virus infection related loss in body weight was expressed as percentage of the initial body weight.</s><s>As soon as animals reached a maximum score of 3 for signs of discomfort and suffering or if a loss in body weight of more than 20 % was observed, mice had to be sacrificed upon cervical dislocation as per regulations.</s><s>At the end of the experiment (day 11) all mice were sacrificed upon cervical dislocation.</s></p><p><s>Data were statistically analyzed by comparison of infected, inhibitor treated mice to infected, PBS treated animals, conducting a one-way ANOVA and Dunnett's multiple comparison test.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 11</head><p><s>Mice treated with LPG 10 SA 0.40 1b or the combination of LPG 10 SA 0.40 1b and oseltamivir carboxylate (Cayman Chemical, 83 µM) were compared using a two-tailed student's t-test.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cryo-TEM imaging</head><p><s>Perforated (1 µm hole diameter) carbon film-covered microscopical 200 mesh grids (R1/4 batch of Quantifoil, MicroTools GmbH, Jena, Germany) were hydrophilized by a 60 s glow discharging at 8 W in a BALTEC MED 020 device.</s><s>Then 5 µl of the aqueous solution of polglycerol sialosides were pipetted to the hydrophilized grid and the supernatant fluid was immediately removed with a piece of filter paper until an ultrathin layer of the sample solution was obtained spanning the holes of the carbon film.</s><s>The sample was instantly vitrified by plunging the grids into liquid ethane using a spring-loaded guillotine-like apparatus.</s><s>The vitrified sample was subsequently transferred under liquid nitrogen into a Tecnai F20 TEM (FEI Company, Hillsboro, Oregon) equipped with field emission gun and operating at 160 kV by the use of a Gatan tomography cryo-holder (Model 914).</s><s>Microscopy was carried out at a 94 K sample temperature using the low-dose protocol of the microscope.</s></p><p><s>Micrographs were taken with an FEI Eagle 4k × 4k CCD camera using the two-fold binning mode.</s><s>The analysis was done using the public domain software ImageJ (U. S. National Institute of Health, Bethesda, Maryland, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results and Discussions</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Design, synthesis, and characterization</head><p><s>To compare different scaffold geometries based on similar chemical constructs, we selected three polyglycerol backbones: 10 kDa linear polyglycerols (LPG 10 ) <ref type="bibr" target="#b48">[31]</ref>, 10 kDa dendritic polyglycerol (dPG 10 ) <ref type="bibr" target="#b49">[32,</ref><ref type="bibr" target="#b50">33]</ref>, and 500 kDa dendritic polyglycerol (dPG 500 ) <ref type="bibr" target="#b39">[25]</ref>.</s><s>To determine the optimum ligand density, polyglycerol sialosides (PGSAs) were synthesized</s></p><formula xml:id="formula_1">M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 12</formula><p><s>with different degrees of SA ligand functionalization (DF) (Scheme 1) in three to four steps by either thiol-ene coupling, i.e., LPG 10 SA 1a-d (DF = 0.10-0.70)</s><s>or copper-catalyzed Sharpless-Huisgen click reaction, i.e., dPG 10 SA 2a-d (DF= 0.05-0.90)</s><s>and dPG 500 SA 3a-d (DF = 0.05-0.70)</s><s>(see Supporting Information).</s><s>To prove that the linkers do not have an effect on the activity in the HAI assay (Fig. <ref type="figure" target="#fig_16">2a</ref>), the control compound LPG 10 SA 0.2 1e (DF = 0.20) was prepared by a copper-assisted click reaction.</s><s>All intermediates and final products were characterized by spectroscopic techniques (see Supporting Information).</s><s>The DF of all polymers with SA ligands was determined by 1 HNMR and the overall molecular weight was calculated based on the parent PG backbone.</s></p><p><s>The size distribution profiles were analyzed by dynamic light scattering (DLS) in phosphate buffered saline (PBS, pH 7.4) (Table <ref type="table">1</ref>, Fig. <ref type="figure" target="#fig_5">1</ref>, Fig. <ref type="figure" target="#fig_28">S1-S3</ref>).</s><s>The hydrodynamic diameter (D h ) for LPG 10 1 was similar to that of dPG 10 2 but smaller than that of dPG 500 3 (Table <ref type="table">1</ref>).</s><s>This confirms an earlier observation that dPG and LPG of the same molecular weight are equally compact <ref type="bibr" target="#b33">[20]</ref>.</s><s>However, we observed a larger increase of D h with increasing DF for the linear LPG 10 1 backbone in comparison to the dendritic dPG 10 2 backbone (Table <ref type="table">1</ref>).</s><s>This shows the higher swelling capacity of the linear LPGSAs' random coil conformation.</s><s>In contrast, dPGSAs swell only slightly because of their more restricted dendritic arrangement.</s><s>In addition, the high molecular weight dPGSAs display only a moderate increase of size compared to the linear analogs.</s><s>Notably, values for D h of LPG 10 SAs were in the same range as observed for the higher molecular weight dPG 500 SAs (Table <ref type="table">1</ref>), which has a 50 times higher mass of the PG core.</s></p><p><s>Morphologies were studied by cryo-TEM (Fig. <ref type="figure" target="#fig_10">S4</ref>).</s><s>dPG 10 SA 0.15 2b and dPG 500 SA 0.20 3b showed particles of spherical morphology with uniform diameters of 5.1 nm and 7.5 nm, respectively (Fig. <ref type="figure" target="#fig_28">1e-f</ref>).</s><s>The somewhat larger sizes observed by DLS measurements are However, the linear polyglycerol sialosides tend to generate very low contrast with the exception of compound LPG 10 SA 0.2 1e where numerous dark spots with a diameter of about 6.3 nm indicate compactly coiled structures of a globular morphology (Fig. <ref type="figure" target="#fig_28">1d</ref> and Fig. <ref type="figure" target="#fig_10">S4</ref>).</s><s>We surmise that the contrast enhancing factor is due to the presence of electron-dense aromatic ring systems of 1e not present in compounds 1a -1d.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Optimal SA functionalization for influenza virus binding inhibition</head><p><s>The potential of multivalent scaffolds with varying DF to prevent binding of the seasonal influenza A/X31 virus (subtype H3N2) to cells was studied by hemagglutination inhibition (HAI) and a flow cytometry assisted cell binding competition assay.</s><s>Table <ref type="table" target="#tab_6">2</ref> provides a subset of the most active compounds.</s><s>See Table <ref type="table" target="#tab_19">S7</ref> for the complete list.</s><s>Non-functionalized scaffolds did not prevent virus-induced hemagglutination at virus quantities equivalent to four hemagglutination units (4 HAU).</s><s>Among the series of dendritic polyglycerols, dPG 10 SA 0.15 2b and dPG 500 SA 0.20 3b are the most effective inhibitors, with hemagglutination inhibition constants KiHAI NP of about 358 nM and 16 nM nanoparticle concentrations, respectively (Fig. <ref type="figure" target="#fig_16">2a</ref> and Table <ref type="table" target="#tab_6">2</ref>).</s><s>Supported by cryo-TEM and DLS analysis, we determined a spherical geometry for all three compounds classes, which allowed us to express the average SA surface density of the multivalent inhibitor (Table <ref type="table">1</ref>).</s><s>This rough estimate enables the comparison of SA density on an inhibitor (Table <ref type="table">1</ref>, Fig. <ref type="figure" target="#fig_32">S11</ref>) with that on a host cell surface as well as with binding sites on the virus surface.</s><s>A typical spherical influenza A virion with a diameter of 120 nm bears around 400-500 HA homotrimers with an intratrimeric binding site spacing of 4-5 nm and a distance of 10-12 nm between two trimer centres <ref type="bibr" target="#b51">[34]</ref> , <ref type="bibr" target="#b52">[35]</ref> and 50-200 SA are present per 100 nm 2 of the host cell surface.</s><s>Translating these numbers into SA binding sites per virus surface area, one can approximate 0.27-0.40</s></p><formula xml:id="formula_2">M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 17</formula><p><s>binding sites per an equilateral triangular HA trimer head surface and 0.5-2.0</s><s>binding sites per nm 2 virus surface <ref type="bibr">[9]</ref>.</s><s>Indeed, ligand density is an important factor of the inhibition potential.</s><s>For 10 kDa PG based PG sialosides, we found a DF in the range of 0.10-0.70 for dPG 10 , 0.40-0.80 for LPG 10 , and about 0.10-0.25 for dPG 500 to be optimal for inhibition.</s><s>dPG 500 SA 0.20 3b with ~2.5 SA/nm 2 is the most effective inhibitor in the dPG500 series with a SA density comparable to the upper range on a cell.</s><s>Increasing DF to values which are even beyond that on the cell surface, however, reduces the inhibitory potential.</s><s>The smaller sized dPG 10 series showed a much broader range of optimum SA densities between 0.2-0.9</s><s>SA/nm 2 (Fig. <ref type="figure" target="#fig_32">S11</ref>).</s></p><p><s>The stronger reduction in inhibitory activity with increasing DF of the dPG 500 3 scaffold series could be related to steric repulsion, which comes more into effect at larger PG-virus interfaces in comparison to that of the smaller sized dPG 10 2 based scaffolds.</s><s>Generally, no inhibitory effect could be detected for polymers with a DF lower than 0.15 even if high amounts were applied (2 mM SA) in the HAI assay (Fig. <ref type="figure" target="#fig_16">2a</ref> and Fig. <ref type="figure" target="#fig_32">S11a</ref>).</s><s>We can exclude any reduction of DF due to enzymatic cleavage of SA monomers from polymers by the viral neuraminidase as the thiol-ene linker attaching SA to the scaffolds is hydrolytically stable.</s></p><p><s>In the series of linear PG sialosides, LPG 10 SA 0.40 1b and LPG 10 SA 0.70 1c were the most effective inhibitors with inhibition constants of 328 nM and 59 nM, respectively (Table <ref type="table" target="#tab_6">2</ref>).</s></p><p><s>The optimum DF was shifted to higher values ranging between 0.40-0.80</s><s>(Fig. <ref type="figure" target="#fig_16">2a</ref>) as compared to the dPG 500 3 based series.</s><s>This may be due to the coiled conformation of the polymer chain (Supporting Information) that reduces the number of SA residues available for binding to the virus.</s><s>However, assuming a globular shaped linear PG (Fig. <ref type="figure" target="#fig_32">S11b</ref>), we were able to deduce an optimal ligand density range between 0.30-0.70</s><s>SA/nm 2 .</s><s>In conclusion, our results clearly indicate that geometry, size, and SA density of the scaffolds are determinants of the inhibition potential.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 18</head><p><s>To illustrate the multivalency effect of inhibitors, which is expressed by the enhancement factor β, KiHAI SA values of the scaffolds were compared with the monovalent α-methylsialoside reported earlier and the experiments with α-2,6-sialyllactose <ref type="bibr">[8,</ref><ref type="bibr" target="#b36">23]</ref> (Table <ref type="table" target="#tab_19">2 and Table S7</ref>).</s><s>The best binding inhibitors LPG 10 SA 0.40 1b, LPG 10 SA 0.70 1c, dPG 10 SA 0.15 2b, and dPG 500 SA 0.20 3b demonstrated up to 15,000-fold enhanced activity compared to α-2,6-sialyllactose and at least 300-fold enhanced activity compared to the reported hemagglutination inhibition value of α-methylsialoside (Table <ref type="table" target="#tab_6">2</ref>) <ref type="bibr" target="#b36">[23]</ref>.</s><s>All compounds were tested in the single-cell binding inhibition assay by flow cytometry at higher viral target concentrations (≈ 16 HAU/µl) to allow for a comparison with our previous studies <ref type="bibr" target="#b43">[29]</ref>.</s><s>(Fig. <ref type="figure" target="#fig_16">2b</ref>, Table <ref type="table" target="#tab_6">2</ref>, Table <ref type="table" target="#tab_19">S7</ref>).</s></p><p><s>In comparison to the dendritic and linear 10 kDa scaffolds, we noticed a much higher inhibition potential for the bigger dPG 500 SA 0.20 3b.</s><s>In line with the results of the HAI assay, dPG 500 SA 0.20 3b demonstrated the best performance in virus-cell binding inhibition, with a half maximal inhibitory concentration (IC 50 ) value of 0.82 µM among all the dPG 500 3-based variants.</s><s>According to the steric shielding model of multivalent inhibitors <ref type="bibr" target="#b37">[24]</ref>, we ascribe this is due to the larger nanoparticle diameter.</s><s>Interestingly, the optimal inhibitors of the LPGSA series, i.e.</s><s>LPG 10 SA 0.40 1b and LPG 10 SA 0.70 1c, which exhibited IC 50 values of 2-4 µM, are almost similar in size as dPG 500 SA 3b (Table <ref type="table">1</ref>).</s><s>Whereas the smaller dPG 10 SA 0.15 2b showed an IC 50 value around ~59 µM, which supports the relevance of steric shielding of larger scaffolds, i.e., 1b/c, 3b (Table <ref type="table">1</ref>)</s></p><formula xml:id="formula_3">M A N U S C R I P T A C C E P T E D Table 1.</formula><p><s>Characterization of LPGSAs (1a-1e) and dPGSAs (2a-2e and 3a-3d).</s></p><p><s>[a] Postfunctionalized M n calculated by using the M n of the polyglycerol core and the experimental degree of functionalization (DF) (see Supporting Information for details).</s><s>[b] The number of sialic acid (SA) units per polymer was calculated from DF by 1 HNMR.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Determination of binding affinity of polyglycerol sialosides to intact virus</head><p><s>To assess affinity constants we conducted microscale thermophoresis (MST) measurements of the most potent multivalent compounds, i.e.</s><s>LPG 10 SA 0.40 1b , LPG 10 SA 0.70 1c , dPG 10 SA 0.15 2b, and dPG 500 SA 0.20 3b titrated against free fluorescent labelled virus (4 HAU).</s></p><p><s>(Fig. <ref type="figure" target="#fig_16">2c, d</ref>).</s></p><p><s>For LPGSAs, Kdapp NP was 10 µM and 0.6 µM for LPG 10 SA 0.40 1b and LPG 10 SA 0.70 1c, respectively.</s><s>In contrast to LPGSAs, both dPG 10 SA 0.15 2b and dPG 500 SA 0.20 3b bound in a biphasic manner to the virus.</s><s>For dPG 500 SA 0.20 3b Kdapp NP was 12.7 nM and 1.3 µM, while for dPG 10 SA 0.15 2b Kdapp NP was 1.5 and 82.5 µM (Fig. <ref type="figure" target="#fig_16">2c</ref>, d and Table <ref type="table" target="#tab_6">2</ref>).</s><s>The origin of the second weaker binding site has still to be identified.</s><s>Sauter et al. <ref type="bibr" target="#b53">[36]</ref> have provided evidence for a second SA binding site on HA.</s><s>The viral neuraminidase may also provide a potential target for multivalent sialosides <ref type="bibr" target="#b55">[37]</ref>.</s></p><p><s>Comparing the inhibition constant values from the HAI assay with dissociation constants from MST we noticed that the KiHAI NP values of the dendritic dPGSAs are close to the first, i.e. the lower dissociation constant Kdapp NP determined with MST.</s><s>In contrast, KiHAI NP values of LPGSAs are 10-30 times lower than their Kdapp NP values.</s><s>We surmise that this could be attributed to steric shielding contributions by LPGSAs that only become fully effective in the virus-cell competition.</s><s>Apart from the high affinity, steric shielding is an important determinant for effective virus-cell binding inhibition.</s><s>Indeed, MST showed that the linear 1c and dendritic 2b inhibitors exhibited affinity values in the same range but the hemagglutination inhibition constants for 1c was 6 fold lower compared to 2b.</s><s>Thus, the affinity to the virus is similar, but the inhibition potential of the water swollen linear polymer</s></p><formula xml:id="formula_4">M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT<label>22</label></formula><p><s>1c is higher due to the steric shielding effect.</s><s>Such an additional steric shielding character of SA conjugated linear scaffolds was also discussed by Whitesides and coworkers, suggesting that the water swollen sugar-coated linear polymer could sterically restrict the virus from binding to the cell surface receptors <ref type="bibr">[10]</ref>.</s></p><p><s>Table <ref type="table" target="#tab_6">2</ref> Inhibitor constants from the hemagglutination and human erythrocyte binding inhibition assay of the most potent functionalized scaffolds and monomeric sialosides.</s><s>Values are expressed in terms of SA concentration or nanoparticle concentration with its SEM (n≥3).</s></p><p><s>For binding inhibition experiments the SE of logIC 50 is given.</s><s>For all compounds see Table <ref type="table" target="#tab_19">S7</ref>.</s><s>For α-methylsialoside the inhibition constant KiHAI SA as well as the dissociation constant Kdapp NP is shown as reported earlier <ref type="bibr" target="#b36">[23,</ref><ref type="bibr" target="#b56">38]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Polyglycerol sialosides interfere with infection and multicyclic virus propagation</head><formula xml:id="formula_5">Influenza A/X31,</formula><formula xml:id="formula_6">M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 23 cells.</formula><p><s>Cell viability was determined 24 h p.i. in order to determine protection from infection at the virus entry step.</s><s>While inhibitors without SA did not inhibit a virus-induced decrease in cell viability, the multivalent sialoside inhibitors showed a protective effect in a dose dependent manner with IC 50 values in the submicro-to low nanomolar range (Fig. <ref type="figure" target="#fig_26">3a-c</ref>, Table <ref type="table" target="#tab_4">3</ref>) (see Table <ref type="table" target="#tab_20">S8</ref> and Fig. <ref type="figure" target="#fig_13">S6</ref> for the entire list of results).</s><s>The values derived from the infection inhibition assay are essentially consistent with those from the above binding inhibition experiments.</s><s>A DF at 0.15-0.20 for the two dPG 10 2-and dPG 500 3-based series and 0.40-0.70 for the LPG 10 1 series turned out to be most efficient in protecting cells from infection.</s><s>For compounds with DF lower than the above mentioned optimum of each scaffold class (Fig. <ref type="figure" target="#fig_16">2a</ref>), inhibition was very low (Fig. <ref type="figure" target="#fig_26">3a-c</ref>).</s><s>Increasing DF far beyond the optimal range reduced the infection inhibition potencies (Fig. <ref type="figure" target="#fig_26">3a-c</ref>).</s><s>Thus, only the favored candidates from binding inhibition experiments, i.e. the selected inhibitor 1b, 1c, 2b, and 3b, were able to preserve maximum cell viability after challenge with the influenza virus.</s><s>The half maximal inhibitory concentrations IC 50NP were in the range of 1.6 to 215 nM for these four compounds.</s><s>The most potent linear low molecular weight inhibitor LPG 10 SA 0.40 1b protected &gt;80% MDCK-II cells from initial infection.</s><s>Importantly, several significantly active compounds in different series did not affect MDCK-II cells viability at inhibitor concentrations up to 500 µM SA equivalents for 24 h.</s><s>The cell viability data of the most potent candidates is given in the Supporting Information (Fig. <ref type="figure">S5</ref>).</s></p><p><s>In a complementary approach, we tested the potential to inhibit infection by monitoring expression of virus nucleoprotein in infected cells 24 h p.i. by immunofluorescence microscopy (Fig. <ref type="figure">S7</ref>).</s><s>We selected those candidates from each series that combined the lowest determined IC 50 value with the lowest molecular weight that is LPG was found to be significantly better than dPG 10 SA 0.15 2b at the concentration of 30 µM SA and above, and throughout all tested concentrations better than dPG 500 SA 0.20 3b (Fig. <ref type="figure" target="#fig_10">4a</ref>).</s><s><ref type="table" target="#tab_20">S8</ref>).</s><s>Error bars: SEM (n≥3).</s><s><ref type="table" target="#tab_20">S8</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Antiviral activity of polyglycerol sialosides in mice</head><p><s>Influenza viruses infect the respiratory tract of mammals.</s><s>To investigate the antiviral activity in in vivo, we tested the selected PG sialosides 1b, 2b, and 3b in a murine model of influenza (Fig. <ref type="figure">5</ref>).</s><s>8-10 weeks old BALB/c mice were infected by intranasal application of inhibitor or control treated A/X31 (100 pfu) and daily controlled in body weight.</s><s>Mice infected with A/X31 lost up to 10 % body weight 4 days post infection, while uninfected mice maintained their body weight in an 11 days experiment (Fig. <ref type="figure" target="#fig_3">S8</ref>).</s><s>According to the time course, the body weights were compared on day 4, being the infection peak, for several inhibitor treatments (Fig. <ref type="figure">5a</ref>).</s><s>Remarkably, treatments with the most potent inhibitors within each PG series caused a significant lower body weight loss in comparison to non-infected animals, reflecting potent protection from infection.</s><s>LPG 10 SA 0.40 1b was outstanding among the tested sialosides, causing an almost complete block of infection by A/X31 in comparison to the noninfected control (Fig. <ref type="figure" target="#fig_3">S8</ref>).</s><s>Also along the 11 days experiment, LPG several days post infection a significantly smaller loss in body weight (Fig. <ref type="figure">5b</ref>) compared to the infected groups treated with PBS only.</s><s>The non-functionalized compound LPG 10 1 at equal molar concentrations did not cause any significant inhibitory effect (Fig. <ref type="figure">5b</ref>).</s></p><p><s>To further evaluate the anti-infective efficacy of LPG 10 SA 0.40 1b, we compared its performance to the approved antiviral medication oseltamivir carboxylate (OC), which is equivalent to the active form of the compound generated by digestive hydrolysis of the ethylester.</s><s>This drug is designed to block viral neuraminidase, which is responsible for virus release from the host cell.</s><s>Using OC at equimolar concentrations as LPG 10 SA 0.40 1b for preincubation with virus inoculate, we observed a much weaker protective effect from the infection (Fig. <ref type="figure">5a and c</ref>).</s><s>Mice treated with 83 µM (32.8 µg/kg) OC still encountered 8 % loss in body weight on day 4.</s><s>Although this concentration is typically used in mice experiments <ref type="bibr" target="#b58">[39]</ref>, we probed also a 10-fold higher concentration (Fig. <ref type="figure" target="#fig_3">S8</ref>).</s><s>Here, although protection against infection was also present at day 3, the inhibitory effect faded at day 4 to 5 as shown by a substantial loss in body weight.</s><s>Mice infected with virus pretreated with both inhibitors, i.e., OC phosphate and LPG 10 SA 0.40 1b, retained their body weight just as well as uninfected mice (Fig. <ref type="figure" target="#fig_3">S8</ref>) and thus the combination therapy boosted the infection inhibition (Fig. <ref type="figure">5a and   c</ref>).</s><s>Similar synergistic effects were observed earlier in vitro by the Whitesides' group who reported that the efficacy of SA-conjugated polyacrylamide increased the inhibition of hemagglutination in the presence of monomeric neuraminidase inhibitors <ref type="bibr" target="#b55">[37]</ref>.</s></p><p><s>The potential to prevent infection of mice was also assessed for the low molecular weight dPG 10 SA 0.15 2b and high molecular weight dPG 500 SA 0.20 3b at 5 mM SA concentrations (Fig. <ref type="figure">5d</ref> and Fig. <ref type="figure" target="#fig_3">S8</ref>).</s><s>Although we observed a significantly reduced body weight loss on day 3 and 4 for dPG 10 SA 0.15 2b and on day 4 for dPG 500 SA 0.20 with respect to All animal experiments were repeated in parallel, but presented in separate figures for clear comprehensibility.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Model for binding of LPGSA and dPGSA with the influenza virus</head><p><s>To rationalize the relevance of the degree of functionalization (DF), the geometry and size of the PGSAs for the potential to inhibit virus-cell binding, we outline here the main</s></p><formula xml:id="formula_7">M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 32</formula><p><s>assumptions and results of a simple model, based on the statistical mechanics of multivalent binding applied to our specific system (for details see Supporting Information).</s><s>The typical hemagglutination inhibition that is due to multivalent constructs is proportional to the construct dissociation constant, which in turn is proportional to the exponential of the binding free-energy ∆G bind .</s><s>Naively, one could think that a larger DF would always correspond to a lower ∆G bind since more binding configurations can form, but this is not always the case.</s><s>For the described systems, the distance between possible binding sites and the length of the ligands makes it impossible for a ligand to be within the binding distance of two different receptors at the same time.</s><s>In this case, binding occurs always with an "indifferent topology," <ref type="bibr" target="#b62">[42]</ref> and the number of binding configurations W is just equal to the number of ligands N within binding distance from the viral receptor.</s><s>In this case, ∆G bind only decreases logarithmically with N, and hence with DF, since the two are directly proportional to each other.</s><s>However, the steric repulsion between a construct and the binding surface <ref type="bibr" target="#b63">[43]</ref> grows linearly with N, since each of the unbound ligands will feel some repulsion from the surface due to excluded volume effects.</s><s>Based on these restrictions and assumptions, the full calculation of ∆G bind is given by:</s></p><p><s>where k B is Boltzmann's constant and T the temperature.</s><s>∆G steric measures the repulsive freeenergy due to steric interactions between a single ligand and the virus surface when the multivalent construct is at binding distance from the surface.</s><s>∆G bond is the energy of formation of a single bond.</s><s>∆S avidity &gt; 0 is the further attractive contribution that arises in the multivalent binding coming from the various achievable distinct possible binding configurations <ref type="bibr" target="#b62">[42]</ref>.</s><s>Given Eq. 1, G bind has a minimum at a particular value of N (and hence</s></p><formula xml:id="formula_8">M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT<label>33</label></formula><p><s>DF).</s><s>Given N opt = 1 /(∆G steric /k B T), a minimum is also observed in the experimental data of Figure <ref type="figure" target="#fig_16">2a</ref>.</s></p><p><s>Two further experimental observations can be explained when calculating the repulsive contribution ∆G steric by modeling the ligands as rigid rods (for details see Supporting Information).</s><s>Meanwhile the leading term in ∆G steric does not depend on the nanoparticle curvature, according to the experimental data, which shows very close values for the optimal DF for both large and small nanoparticles.</s><s>Furthermore, within the same description, ∆G steric /k B T is more negative for a ligand grafted onto a linear polymer compared to grafting it to an impenetrable surface of a nanoparticle.</s><s>This also provides a further reason, besides the ligands' inaccessibility in a coiled structure, why the minimum for the LPGSA shifts to higher DF values.</s><s>Whereas the exact value of N opt depends on the specific model used to describe the ligand, and an accurate calculation might require detailed molecular simulations, the possible presence of a minimum of Ki (Fig. <ref type="figure" target="#fig_16">2a</ref>) arises from a very general mechanism of competition between binding entropy and steric repulsion and is thus expected to be a general aspect of our system.</s><s>This simple statistical model rationalizes the relevance of DF, as well as the morphology and the size of PGSAs for the potential to inhibit virus-cell binding (for details see Supporting Information).</s><s>In particular, it explains (i) the nonmonotonic behavior and the presence of the experimentally observed optimum of DF, and why that optimum is (ii) similar for large and small nanoparticles, (iii) but shifted to higher values for linear polymers.</s></p><p><s>Based on our finding that the scaffold geometry affects multivalent interaction, we here provide a hypothesis on the scaffold topology of the virus bound SA polyglycerols.</s><s>By HA ectodomain complexed with SA that the SA binding sites were located in shallow pockets on the globular head domain of HA trimmers <ref type="bibr" target="#b64">[44]</ref>.</s><s>However, the three binding sites were not orientated in the most distal direction but instead radially outwards.</s><s>Although both intra-trimeric and inter-trimeric binding of inhibitors were conceivable due to this spatial arrangement of the binding sites, inter-trimeric interactions were more likely.</s><s>The situation is fitted to the scale to illustrate that the LPG 10 SA and the dPG 500 SA which are similar in size, caught up to three binding sites on different trimers (Fig. <ref type="figure" target="#fig_13">6a and 6c</ref>), whereas the smaller dP 10 GSA series could reach only two of them (Fig. <ref type="figure" target="#fig_13">6b</ref>).</s><s>The change in shape of PGSAs upon binding with the virus particles will demand a high entropic cost and might be unlikely in this particular case.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSIONS</head><p><s>We have shown that the nontoxic low-molecular weight polyglycerol scaffolds decorated with sialic acid as the virus receptor-mimicking ligand may act as efficient multivalent inhibitors of influenza virus activity in vitro as well as in vivo.</s><s>We compared two different general geometries, linear and dendritic polyglycerol sialosides, which differ in both molecular weight and the multiplicity of SA units.</s><s>We have optimized the ligand densities for the linear and dendritic PGs to achieve a high inhibitory potency against influenza virus.</s><s>This study clearly reveals that high ligand densities on the multivalent architectures are not necessary for effective influenza virus inhibition.</s><s>By a rational and systematic approach, we have demonstrated that the linear sialic acid-functionalized PGs are more potent multivalent inhibitors of influenza A virus infection than the dendritic PG scaffolds in vitro and in vivo.</s></p><p><s>Our results indicate that at a comparable binding affinity to the virus, the higher inhibitory      <ref type="table" target="#tab_20">S8</ref>).</s><s>Error bars: SEM (n≥3).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT</head><p><s>51 Table <ref type="table">1</ref>.</s><s>Characterization of LPGSAs (1a-1e) and dPGSAs (2a-2e and 3a-3d).</s></p><p><s>[a] Postfunctionalized M n calculated by using the M n of the polyglycerol core and the experimental degree of functionalization (DF) (see Supporting Information for details).</s></p><p><s>[b] The number of sialic acid (SA) units per polymer was calculated from DF by 1</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D</head><p><s>Table <ref type="table" target="#tab_6">2</ref> Inhibitor constants from the hemagglutination and erythrocyte binding inhibition assay of the most potent functionalized scaffolds and monomeric sialosides.</s><s>Values are expressed in terms of SA concentration or nanoparticle concentration with its SEM (n≥3).</s><s>For binding inhibition experiments the SE of logIC 50 is given.</s><s>For all compounds see Table <ref type="table" target="#tab_19">S7</ref>.</s></p><p><s>For α-methylsialoside the inhibition constant KiHAI SA as well as the dissociation constant Kdapp NP is shown as reported earlier <ref type="bibr" target="#b36">[23,</ref><ref type="bibr" target="#b56">38]</ref>.</s><s>Signal curves for microscale thermophoresis (Figure <ref type="figure">S9</ref>) 29</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Compound</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D</head><p><s>Erythrocyte binding inhibition experiments (Figure <ref type="figure" target="#fig_31">S10</ref>) 30</s></p><p><s>Hemagglutination inhibition in respect to ligand density (Figure <ref type="figure" target="#fig_32">S11</ref>) 31</s></p><p><s>Virus binding inhibition experiments (Table <ref type="table" target="#tab_19">S7</ref>) 31</s></p><p><s>IC 50 values from cell viability based infection inhibition experiments (Table <ref type="table" target="#tab_20">S8</ref>) 32</s></p><p><s>Theoretical model for virus binding with LPGSA and hPGSA 33 The degree of branching (DB) was calculated using inverse gated (IG) 13 C NMR as reported in literature.</s><s>DB as determined by IG 13 CNMR= 62%</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.2.">Synthesis of LPGSAs 1a-1e</head><p><s>LPGSAs 1a-1d were synthesized in three steps starting from LPG</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthesis of LPG-allyl</head><p><s>LPG 10 1 (0.1 g, 0.14 mmol OH to be functionalized) was dried at 60 °C overnight under high vacuum.</s><s>Dried LPG was dissolved in dry DMF (3 mL) and cooled to 0 °C.</s><s>To the stirred solution of LPG in dry DMF at 0 o C, NaH (4.59 mg, 0.18 mmol, 1.3 eq., 95%) was added.</s><s>After addition ice bath was removed and the temperature of the reaction mixture was allowed to reach room temperature.</s><s>The reaction mixture was allowed to stir at room temperature for 2 hours and cooled down again to 0 o C. The allyl bromide (24.12 µL, 0.28</s></p><formula xml:id="formula_9">M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT</formula><p><s>59 mmol, 2.0 eq.) in dry DMF (1 mL) was added drop wise to the reaction mixture using a syringe at 0 o C. The ice bath was removed and after stirring for 16 hours at room temperature the reaction was quenched with water.</s><s>The DMF was removed in vacuum and the resulting mixture was dialyzed in MeOH to afford 90 mg of LPG-allyl (DF = 0.10).</s></p><p><s>Degree of allylation was quantified by 1 H NMR. Yield = 84%. 1</s></p><p><s>The degrees of functionalization (DF) in the different reactions were confirmed by 1 H NMR of the pure product correlating the allyl protons at 5.9 -5.8 ppm with the polyglycerol backbone protons (3.7 -3.4).</s><s>Table <ref type="table">S1</ref> shows the yields and different degrees of allylation achieved as determined by 1 H NMR.</s></p><p><s>Table <ref type="table">S1</ref> Yield and degree of functionalization of LPG-allyl.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthesis of LPGSA protected</head><p><s>LPG-allyl (DF=0.10)</s><s>(0.08 g, 0.102 mmol of allyl group) was dissolved in dry methanol pressure UV lamp at room temperature for 2 hours.</s><s>The reaction completion was monitored by 1 H NMR by looking for the disappearance of resonance peak corresponding to one of the allyl protons at δ = 5.85 ppm.</s><s>The reaction mixture was dialyzed to remove DMPA and excess of sialic acid derivative against methanol to afford 107.8 mg LPGSA protected (DF=0.10)</s><s>with a quantitative conversion (determined by 1 H NMR). Yield= 82%. 1   <ref type="table" target="#tab_6">S2</ref> shows the reaction yields for the preparation of LPGSA protected with different DFs.</s></p><p><s>Table <ref type="table" target="#tab_6">S2</ref>.</s><s>Yield and degree of functionalization of LPGSA protected .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthesis of LPGSA 1a-1d</head><p><s>2M NaOH (5 mL) was added to the LPGSA protected (DF=0.10)</s><s>(0.09 g, 0.07 mmol of ligands) and stirred at room temperature for 2 hours.</s><s>The reaction mixture was neutralized by adding 2M HCl solution and dialyzed against water for 3 days.</s><s>The solvent of the dialysis was changed thrice a day.</s><s>The aqueous solution obtained after dialysis was lyophilized to afford the pure 72.5 mg LPGSA 1a with a quantitative conversion (determined by 1</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D</head><p><s>Table <ref type="table" target="#tab_21">S3</ref> shows the yields, DF, and the average molecular weight as determined by 1 H NMR and GPC of the final compounds LPGSA 1a-1d.</s></p><p><s>Table <ref type="table" target="#tab_21">S3</ref>.</s><s>Yields and calculated molecular weights of LPGSA 1a-1d.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>LPGSA</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthesis of LPG-OMs (DF = 0.20)</head><p><s>LPG 10 1a (0.1 g, 0.27 mmol OH to be functionalized) was dried at 60 °C overnight under high vacuum.</s><s>Dried LPG was dissolved in dry DMF (3 mL) followed by addition of TEA (0.075 mL, 0.54 mmol, 2.0 eq. with respect to OH group) and cooled to 0 °C.</s><s>Then methane sulphonyl chloride (MsCl) (27.16 µL, 0.35 mmol, 1.3 eq. with respect to OH group) dry DMF (1 mL) was added drop wise using a syringe at 0 °C.</s><s>After stirring the solution for 1 hours at 0 °C, the mixture was allowed to reach room temperature and was stirred for 16 h.</s><s>The dry DMF was removed in vacuo and the resulting mixture was dialyzed in MeOH to afford 96.4 mg of LPG-OMs as a honey-like product.</s><s>Degree of mesylation was quantified as 20% by 1 H NMR. Yield = 80%.</s><s>The degrees of functionalization were confirmed by 1 H NMR of the pure products correlating the CH 3 -Ms at 3.16 ppm with the polyglycerol backbone protons at 4.43-3.52</s><s>ppm.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthesis of LPG-N 3 (DF=0.20)</head><p><s>LPG-OMs with DF = 0.20 (0.09 g, 0.20 mmol OMs) was dissolved in dry DMF (5 mL) in a one-neck flask equipped with a refluxing condenser.</s><s>NaN 3 (65.52</s><s>mg, 1.00 mmol, 5 eq.</s></p><p><s>with respect to OMs group) was added to the reaction mixture and stirred at 60 °C for 1 day.</s><s>The resulting salts were filtered off.</s><s>DMF from the reaction mixture was evaporated using a rotary evaporator and the residue was dialyzed in MeOH to obtain 0.081 g of LPG-N 3 with a quantitative conversion (determined by 1 H NMR). Yield= 98%.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthesis of LPGSA 1e</head><p><s>LPG-N 3 with DF=0.20 (0.07g, 0.17 mmol N 3 groups) was dissolved in 4 mL of THF-H</s></p><p><s>(1:1) solvent mixture followed by addition of solution of prop-2-ynyl α-thiosialoside (120.6 mg, 0.22 mmol, 1.3 eq. with respect to N 3 groups) in THF (1 mL).</s><s>CuSO 4 .5H 2 O (8.4 mg, 0.034 mmol, 0.2 eq with respect to N 3 groups) was dissolved in 0.2 mL of H 2 O and added to the solution of sodium ascorbate (67.3 mg, 0.34 mmol, 2.0 eq with respect to When the peak at ~2100 cm -1 corresponding to azide stretching frequency completely disappeared, solvent of the reaction mixture was evaporated at rotary evaporator.</s><s>2M</s></p><p><s>NaOH (8 mL) was added to the residue, and stirred at room temperature for 2 h.</s><s>The reaction mixture was neutralized by adding 2M HCl solution and dialyzed against water and aqueous EDTA solution for 2 days and again using water for 4 days.</s><s>The solvent of the dialysis was changed thrice a day.</s><s>The aqueous solution obtained after dialysis was lyophilized to afford the pure 98.5 mg LPGSA 1e with a quantitative conversion Yield= 78%.</s><s>M w(NMR) = 31.7 kDa, M w(GPC/H2O) = 29.7 kDa, M n(GPC/H2O) = 23.1 kDa, PDI = 1.28.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.3">Synthesis of dPGSA derivatives</head><p><s>dPGSAs 2a-2e and 3a-3d were synthesized starting from dPG 10 2 and dPG 500 3 respectively in three steps: mesylation, substitution by azide, and copper-catalyzed Sharpless/Huisgen click reaction dPG-N 3 with prop-2-ynyl α-thiosialoside (Scheme S2).</s></p><p><s>Prop-2-ynyl α-thiosialoside was synthesized using Roy 5 and a slightly modified procedure of Ogura 6 .</s><s><ref type="table" target="#tab_15">S4</ref> shows the yields and different degree of mesylation achieved in different reactions.</s></p><p><s>*dPG 500 3 was not dried at 60 °C overnight under high vacuum.</s><s>Instead dPG 500 3 was dissolved in pyridine, and pyridine was removed under high vacuum at room temperature.</s><s>The procedure was repeated thrice to obtain moisture free dPG 500 3.</s></p><p><s>The degrees of functionalization were confirmed by 1 H NMR of the pure products correlating the CH 3 -Ms at 3.15 ppm with the polyglycerol backbone protons.</s><s>Synthesis of dPG-N 3 dPG-OMs, DF = 0.05 (0.08 g, 0.051 mmol OMs) was dissolved in dry DMF (5 mL) in a one-neck flask equipped with a refluxing condenser.</s><s>NaN 3 (16.25 mg, 0.25 mmol, 5 eq.</s></p><p><s>with respect to OMs group) was added to the reaction mixture and stirred at 60 °C for 1 day.</s><s>The resulting salts were filtered off.</s><s>DMF from the reaction mixture was evaporated using rotary evaporator and the residue was dialyzed in MeOH to obtain 0.071 g of dPG-N 3 with a quantitative conversion (determined by 1 H NMR). Yield= 88%.</s><s><ref type="table" target="#tab_16">S5</ref> shows the yields and different degree of azidation achieved in different reactions.</s><s>Dashed lines are derived from a four parametric sigmoidal fit to determine IC 50 values (Table <ref type="table" target="#tab_19">S7</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Theoretical model for virus binding with LPGSA and dPGSAs</head><p><s>The aim of this section is to show how a simple model based on the statistical mechanics of binding can be used to rationalize the observed experimental data regarding the inhibition e ciency of ligands-functionalized nanoparticles and polymers.</s><s>More precisely, we aim at understanding trends in inhibition e ciency as a function of the degree of functionalization.</s><s>The starting point to consider is that the hemagglutination inhibition e ciency for multivalent constructs is typically proportional to their dissociation constant <ref type="bibr">[7]</ref> or in other words proportional to the exponential of the binding strength, ∆G bind .</s><s>∆G bind depends on the trade-o between how much binding free-energy is gained through ligand-receptor bonds formation and how much is lost via steric repulsion, since once brought within binding distance from the virus' surface ligands will also feel a steric repulsion due to excluded volume e ects.</s><s>This trade-o depends on the spatial arrangement of both ligands and receptors, which controls their binding freeenergy, and molecular quantities such as the length and rigidity of the ligands <ref type="bibr">[8,</ref><ref type="bibr">9]</ref>.</s><s>For this reason, in order to understand the binding strength of our multivalent constructs to viruses, it is important to consider the spatial organization of the sialic acid (SA) receptors on the viral surface, as well as that of SA itself on the multivalent construct.</s><s>On a typical influenza virus with radius 50 nm, around 400 HA proteins are present, each having 3 binding sites for SA.</s><s>From these values, the average distance between receptors (without accounting for spatial correlations) can be estimated as d RR =  is much larger than the ligands length, ligands cannot be within binding distance from two di erent receptors at once.</s><s>In this case, an "indifferent topology" of binding occurs <ref type="bibr">[10]</ref> where only one bond can be formed at any given time between the N = 3 ligands that can interact with the viral surface and the receptor, leading to a binding contribution due to avidity entropy <ref type="bibr">[10]</ref> of</s></p><formula xml:id="formula_13">∆G = −T∆S avidity = −k B T logN<label>(1)</label></formula><p><s>If N is the number of ligands that can interact with the viral surface at any given time, either via forming a bond with a viral receptor, or because they are sterically repelled by the viral surface, there are N binding configurations, each of which have only one of the N ligands bound, and the others N -1 unbound.</s><s>Note that N is directly proportional to the degree of functionalization DF.</s><s>This binding scenario is the so called "indi erent topology" described by Kitov and Bundle <ref type="bibr">[10]</ref> where binding of a ligand exclude the concurrent binding of others.</s><s>Under these conditions, and assuming to a first inter-receptor distance is too large compared to the ligands length, as previously explained).</s><s>Hence, ∆G bind grows logarithmically with N.</s><s>However, the number of unbound ligands which can sterically interact with the surface of the virus grows linearly with N, and so does their induced repulsive interaction.</s><s>Since the binding energy decreases slower than the steric repulsion increases, their sum will attain a minimum at a specific value due to the compromise between these opposite terms.</s><s>In fact, by taking the derivative of both sides of equation Eq. 2, we find that the lowest attainable free-energy, i.e. the lower dissociation constant and hence the optimal hemagglutination inhibition, is at:</s></p><formula xml:id="formula_14">N opt = k B T ∆G steric<label>(4)</label></formula><p><s>clearly, such a minimum will be e ectively observed only if N opt &gt; N max , where N max is obtained at the highest possible degree of functionalization, i.e.</s><s>DF = 100%.</s><s>This simple model does not only predict the existence of a minimum, but since ∆G steric depends on molecular parameters of our system it can tell us how this minimum shift as a function of the ligand molecular structure.</s><s>Let us thus treat ligands as rigid rods of length L, grafted to a point at a binding distance h from the viral surface (clearly h &lt; L for binding to occur).</s></p><p><s>In this case, Z u can be calculated for ligands grafted on a hard surface of curvature radius R, representing a nanoparticle, or grafted to an (ideal) polymer.</s><s>Considering for simplicity the surface of the virus as a flat surface (a good approximation given that viruses are much larger than the constructs we study (R virus ≈ 50 nm &gt;&gt; R nanoparticle ≈ R polymer ), we obtain the following two expressions: 1.</s><s>Since the repulsive free-energy for ligands coated on a nanoparticle ∆G steric nanoparticle , does not depend in its leading term on the nanoparticle radius, the model predicts that both small and large dPGSA have roughly the same optimal degree of functionalization.</s></p><p><s>2. Given that ∆G steric polymer &lt; ∆G steric nanoparticle (independently on the binding distance), we predict N opt (and hence the optimal degree of functionalization DF) to shift at higher values for the linear constructs when compared to nanoparticles to which the same ligands are grafted.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>M A N U S C R I P T A C C E P T E D</head><p><s>ACCEPTED MANUSCRIPT</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>virus-inhibitor complex was mixed with 40 µl of a 1% human erythrocyte solution (~2•10 6 cells/µl) and incubated for 30 min at rt. Unbound virus was removed upon centrifugation for 10 min at 1500 x g.</s><s>The resuspended cell pellet was analyzed for R18 fluorescence by flow cytometry (Beckton Dickinson FACSAria TM flow cytometer).</s><s>Data were acquired by using BD CellQuest software and analyzed with FlowJo 10.0 software.</s><s>From each measurement, a single cell population was gated and median fluorescence was normalized to a PBS-treated virus control.</s><s>Dose response curves of mean values (n≥3) were fitted using a four parametric logistic fit to obtain IC 50 values.</s><s>The asymmetric standard error (SE) of the fit is given for logIC 50 .</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>8 as</head><label>8</label><figDesc><div><p><s>shown in Fig.S9.</s><s>Data were analyzed by using Affinity Analysis Software (Nanotemper, v2.0) and plotted with Graphpad Prism 5.</s><s>In order to determine the noise level, triplicates of the same virus dilution were measured leading to ∆F ≈ 5 FU (Fig.S9).</s><s>The change in fluorescence was expressed as ∆Fnorm (‰), and represented values after subtraction of background and correlation to the initial fluorescence before IR laser activation.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc><div><p><s>fact that DLS measures the hydrodynamic radius, which includes the hydration shell undetectable by TEM.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Scheme 1 .</head><label>1</label><figDesc><div><p><s>Scheme 1. Synthesis of linear and dendritic polyglycerol sialosides of different size and</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig. 1 . 16 (</head><label>116</label><figDesc><div><p><s>Fig. 1.</s><s>Size analysis of the linear and dendritic polyglycerol based inhibitors by DLS and</s></p></div></figDesc><graphic coords="17,72.00,362.28,470.88,290.28" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head></head><label></label><figDesc><div><p><s>[c] Determined by 1 HNMR analysis.</s><s>[d] Determined from DLS in aqueous buffer (PBS, pH 7.4), the values represent the means of at least three measurements ± standard deviation of the volume distribution profile.</s><s>[e] The average SA densities on the different scaffolds were calculated assuming the spherical morphologies of PGs, thus dividing the number of SA units with the surface area of the corresponding backbone [LPG 10 (A nm 2 ) = 151, dPG 10 (A nm 2 ) = 113, dPG 500 (A nm 2 ) = 488].</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Fig. 2 . 21 (</head><label>221</label><figDesc><div><p><s>Fig. 2. Virus binding and inhibition assays: a) Hemagglutination inhibition constants per</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3. Inhibition of infection of MDCK II cells by influenza virus A/X31 (MOI 0.05)</s></p></div></figDesc><graphic coords="27,101.76,188.64,392.28,464.28" type="vector_box" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head>Fig. 4 .</head><label>4</label><figDesc><div><p><s>Fig. 4. Inhibition of virus infection: a) Inhibition by 10 to 300 µM SA of the most potent</s></p></div></figDesc><graphic coords="28,72.00,127.20,450.84,427.08" type="vector_box" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_11"><head>31 Fig. 5 .</head><label>315</label><figDesc><div><p><s>Fig. 5. Inhibition of influenza A/X31 virus infection of BALB/c mice by SA functionalized</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_12"><head></head><label></label><figDesc><div><p><s>means of the determined diameters of the compounds and on the basis of the spatial distribution of HA trimers on the virus surface, an estimation of the possible number of multivalent interactions was made.</s><s>It could be shown by X-ray crystallographic studies of the M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 34</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_13"><head>Fig. 6 .</head><label>6</label><figDesc><div><p><s>Fig. 6.</s><s>Multivalent interactions of three different polyglycerol sialosides with trimeric HA on</s></p></div></figDesc><graphic coords="36,72.00,348.00,451.32,167.64" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_14"><head>1 .</head><label>1</label><figDesc><div><p><s>Scheme 1</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_15"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>Size analysis of the linear and dendritic polyglycerol based inhibitors by DLS and</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_16"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2. Virus binding and inhibition assays: a) Hemagglutination inhibition constants per</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_17"><head>Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3. Inhibition of infection of MDCK II cells by influenza virus A/X31 (MOI 0.05)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_18"><head>Fig. 4 . 1 .Fig. 5 .Fig. 6 .</head><label>4156</label><figDesc><div><p><s>Fig. 4. Inhibition of virus infection: a) Inhibition by 10 to 300 µM SA of the most potent</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_19"><head>1e 9 1. 3 10 Synthesis of dPGOMs 11 Synthesis of dPGN 3 12 Synthesis of dPGSAs 2a-2e and 3a-3d 13 1. 4 16 1.6 1 H NMR spectra of LPGSAs and dPGSAs 19 Supporting figures and tables 22 27 M</head><label>93101112134161192227</label><figDesc><div><p><s>Synthesis of dPGSAs 2a-2e and 3a-3d (Scheme S2) Inverse gated (IG)13 CNMR spectra of dPG 10 2 and dPG 500 3 15 1.51 H NMR spectra of intermediate compounds LPGallyl, LPGSA protected, LPGOMs, LPGN 3 , dPGOMs, dPGN 3 Number and intensity distribution profiles in DLS (Figure S1-S3) 22 Cryo-TEM images of compounds 1e, 2b, and 3b (Figure S4) 25 Cell viability assay (Figure S5) 26 IC 50 values of infection inhibition experiments (Figure S6)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_20"><head>LPG 10 1</head><label>10</label><figDesc><div><p><s>was synthesized by the previously reported procedure[1]  and characterized by the1 H NMR and GPC (H 2 O) for the determination of absolute molecular weight and dispersity using a pullulan standard.GPC (H 2 O): M n = 10.1 kDa, M w = 13.1 kDa, D = 1.29 dPG 10 2 was synthesized using the previously reported procedure[2]  characterized by NMR and GPC (H 2 O) for the determination of absolute molecular weights and dispersity.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_21"><head>[ 3 ]</head><label>3</label><figDesc><div><p><s>GPC (H 2 O): M n = 12.3 kDa, M w = 16.3 kDa, D = 1.32 Degree of branching (DB) as determined by IG 13 CNMR = 59% dPG 500 3 was synthesized using a different procedure as reported by Imran Ul-Haq et.al [4] and characterized by NMR, GPC, and MALLS.</s><s>GPC (DMF): M n = 481 kDa, M w = 552 kDa, PDI = 1.15 GPC-MALLS (H 2 O): M n = 436 kDa, M w = 481 kDa, PDI =1.10</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_22"><head>10 1 :</head><label>1</label><figDesc><div><p><s>Scheme S1.</s><s>Synthesis of linear polyglycerol sialosides (LPGSAs 1a-1e).</s><s>Sialic acid</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_23"><head>( 3</head><label>3</label><figDesc><div><p><s>mL).</s><s>Added freshly prepared sialic acid thiol intermediate5 (77.46 mg, 0.153 mmol, 1.5 eq.) and 2,2-dimethoxy-2-phenylacetophenone (DMPA) as radical initiator (26.14 mg, 0.102 mmol, 1.0 eq.).</s><s>The catalytic amount of tris(2-carboxyethyl)phosphine hydrochloride (TCEP-HCl) was added to the reaction to avoid oxidation of the thiol intermediate.</s><s>The solution was degassed by flushing argon through the reaction mixture for 10 minutes.</s><s>The reaction mixture was stirred and irradiated with UV light using a high</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_24"><head>1 H</head><label>1</label><figDesc><div><p><s>NMR (500 MHz, D 2 O): δ(ppm) = 4.43-3.52</s><s>(m, CH 2 and CH, PG scaffold); 3.16 (brs, CH 3 mesyl), IR (film): ν = , 2361, 1709, 1457, 1362, 1184, 971, 813, 753 cm −1 .</s><s>The Figure S13 shows the 1 H NMR of the LPG-OMs (DF=0.20).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_25"><head>1 H</head><label>1</label><figDesc><div><p><s>NMR (500 MHz, CD 3 OD): δ(ppm) = 3.72-3.38</s><s>(m, CH 2 and CH, LPG scaffold), IR (film): ν = 3349, 2922, 2878, 2098 (N 3 ), 2034, 1633, 1540, 1160, 1041 cm −1 .</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_26"><head>N 3</head><label>3</label><figDesc><div><p><s>groups) in 0.4 mL H 2 O.</s><s>The resultant solution of salts in water was added drop wise to the solution containing LPGN 3 and prop-2-ynyl α-thiosialoside.</s><s>The reaction mixture was degassed thoroughly with argon for 5 minutes and then allowed to stir for 3 days at room temperature under argon atmosphere.</s><s>The progress of the reaction was monitored by IR.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_27"><head></head><label></label><figDesc><div><p><s>Scheme S2.</s><s>Synthesis of dPGSAs 2a-2e and 3a-3d.</s></p></div></figDesc><graphic coords="66,315.72,420.12,63.72,63.36" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_28"><head>1 H</head><label>1</label><figDesc><div><p><s>NMR (500 MHz, D 2 O): δ (ppm) = 4.00-3.39</s><s>(m, CH 2 and CH, PG scaffold), 1.40 (m, CH 2 core), 0.89 CH 3 core), IR (film): ν = 2873, 2361, 2102 (N 3 ), 1457, 1273, 1122, 668 cm −1 .</s><s>Table</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_29"><head>Figure S1 .Figure S2 .Figure S3 . 3 )Figure S4 .</head><label>S1S2S33S4</label><figDesc><div><p><s>Figure S1.</s><s>The number and intensity distribution profiles of linear polyglycerol (LPG 10 1) and polyglycerolsialosides (1a-e) as observed by dynamic light scattering (DLS).</s><s>All samples were analyzed at 1mg/ml in aqueous PBS (pH 7.4, 150 mM NaCl) at 25 o C.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_30"><head>Figure S5 .Figure S7 .Figure S8 .Figure S9 .</head><label>S5S7S8S9</label><figDesc><div><p><s>Figure S5.</s><s>Cell viability plots.</s><s>After a 24 h incubation of MDCK II cells with compounds representing the most potent inhibitors of each PG scaffold class, cell viability was determined using a CellTiter AQueous One Solution (Promega).</s><s>Error bars represent the SEM (n≥3).</s></p></div></figDesc><graphic coords="81,109.44,158.16,394.32,207.12" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_31"><head>Figure S10 .</head><label>S10</label><figDesc><div><p><s>Figure S10.</s><s>Erythrocyte binding inhibition experiments: Dose dependent binding inhibition plots of R18 labeled X31 virus (16 HAU/µl) to 1% (v/v) red blood cells in the presence of a) LPG 10 , b) dPG 10, and c) dPG 500 based inhibitor scaffolds.</s><s>Error bars represent the SEM (n≥3).</s></p></div></figDesc><graphic coords="86,141.36,172.32,312.60,401.16" type="vector_box" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_32"><head>Figure S11 .</head><label>S11</label><figDesc><div><p><s>Figure S11.</s><s>Hemagglutination inhibition in respect to ligand density with either LPG 10 1 and dPG 10 2, (a) or dPG 500 3 (b) with different sialic acid (SA) densities.</s><s>Error bars represent the SEM (n≥3).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_33"><head></head><label></label><figDesc><div><p><s>pair of receptors on the same HA unit is about 4.5 nm.</s><s>Since both distances are much larger than the length of a SA ligand, the latter cannot be at the same time within binding distance of two di erent receptors (a possible realization of the virusmultivalent construct system is schematically depicted in Fig.S12for clarity).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_34"><head>Figure S12 .</head><label>S12</label><figDesc><div><p><s>Figure S12.</s><s>Schematic representation of a multivalent construct bound to a surface in</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_35"><head></head><label></label><figDesc><div><p><s>formation energy for a single bond ∆G bond is roughly the same for all ligands-receptor pairs, the interaction free-energy of the multivalent construct is: Eq. 2 Z u(b) is the partition function for an unbound (bound) ligand with respect to that of an unbound ligand not confined by the virus surface, and as such is a function of the virusnanoparticle binding distance h, as well as of the length and rigidity (or, more precisely, the molecular structure) of the specific ligand used and the construct to which it is grafted (see Scheme 1).</s><s>For this reason, in Eq. 2, we can identify − log Z u = ∆G steric and − log Z b Z u = ∆G bond as the (repulsive) steric contribution and the (attractive) bond contribution to the binding free-energy due to a single ligand, respectively, and ∆S avidity = k B log N is the socalled avidity entropy contribution arising due to multivalent binding, which depends on the number of possible binding configurations the construct can achieve[10].The microscopic picture behind this model is easily explained.</s><s>By increasing the number of ligands on the nanoparticle available for binding, one increases the binding free energy by ∆G bind = − T∆S avidity = − k B T log(N), the entropic contribution due to all possible binding configurations considering that only one of them can bind a receptor at the same time (note that the bonding contribution would be instead proportional to N if each ligand can bind concurrently a di erent receptor, but this is impossible in our system since theM A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 90</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_36"><head></head><label></label><figDesc><div><p><s>. 4, these formulas agree with two other experimentally observed behaviors:</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="48,72.00,478.32,451.32,167.52" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="78,167.52,109.44,291.24,202.44" type="vector_box" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="79,201.60,342.36,305.76,230.88" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="82,125.52,92.76,343.80,170.64" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="84,72.00,175.44,451.68,309.96" type="vector_box" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>MW SA DF )* KiHAI SA [µM] KiHAI NP [nM] Binding inhibition IC 50 SA [mM] Binding inhibition IC 50 NP [µM] Kdapp NP [µM]</head><label></label><figDesc></figDesc><table><row><cell>α-methylsialoside</cell><cell>2000</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell>2800±300</cell></row><row><cell>α-2,6-sialyllactose</cell><cell>100000</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell>-</cell></row><row><cell>LPG 10 SA 0.40 1b</cell><cell>19.5±5.9</cell><cell>328±98</cell><cell>0.22+0.03</cell><cell>3.74+0.50</cell><cell>10.10±2.90</cell></row><row><cell>LPG 10 SA 0.70 1c</cell><cell>5.9±2.7</cell><cell>59±27</cell><cell>0.22+0.02</cell><cell>2.20+0.20</cell><cell>0.60±0.32</cell></row><row><cell>dPG 10 SA 0.15 2b</cell><cell>9.3±1.7</cell><cell>358±66</cell><cell>1.54+0.08</cell><cell>59.1+3.1</cell><cell>1.46±0.65</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>and 82.5±24.0</cell></row><row><cell>dPG 500 SA 0.20 3b</cell><cell>20.3±4.7</cell><cell>16±4</cell><cell>1.01+0.05</cell><cell>0.82+0.05</cell><cell>0.013±0.006</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>and 1.35±0.43</cell></row></table><note><p><s>at a multiplicity of infection (MOI) of 0.05, was pretreated with inhibitors (most potent inhibitors and controls) for 30 minutes and used to infect MDCK-IICompound (PG</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head></head><label></label><figDesc><div><p><s>infection of MDCK-II cells at MOI 0.1.</s><s>Whereas upto 80% of cells exposed to PBS or control inhibitor (unfuntionalized scaffold) treated virus were infected, the linear polyglycerol LPG 10 SA 0.40 1b was able to significantly reduce infection.</s><s>The LPG 10 SA 0.40 1b</s></p></div></figDesc><table><row><cell>ACCEPTED MANUSCRIPT</cell></row><row><cell>M A N U S C R I P T</cell></row><row><cell>A C C E P T E D</cell></row></table><note><p><s>10 SA 0.40 1b, dPG 10 SA 0.15 2b, and dPG 500 SA 0.20 3b, respectively.</s><s>Again, A/X31 was preincubated with different concentrations of inhibitors from 10 -300 µM SA, for 30 min before</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 3</head><label>3</label><figDesc><div><p><s>Mean values (n≥3) of the half maximal inhibitory concentration (IC 50 ) of selected inhibitors after infection of MDCK-II cells at an MOI of 0.05 for 24 h.</s><s>For infection inhibition experiments the SE of logIC 50 is given.</s><s>For a list of all compounds see Table</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head></head><label></label><figDesc><div><p><s>1 mM SA equivalents (m NP = 3.3 or 0.7 mg/kg, m SA = 1.9 or 0.4 mg/kg, n SA = 6.25 or 1.25 µmol/kg), which corresponds to 83 µM or 17 µM tailored sialic acid, both showed on</s></p></div></figDesc><table><row><cell></cell><cell>ACCEPTED MANUSCRIPT</cell></row><row><cell>5 mM or</cell><cell></cell></row><row><cell>Compound (PG MW SA DF ) LPG 10 1 LPG 10 SA 0.40 1b LPG 10 SA 0.70 1c dPG 10 SA 0.15 2b dPG 500 SA 0.20 3b</cell><cell>Infection inhibition IC 50 NP [nM] 500000.00 2.35+0.83 3.69+0.91 215.15+6.92 1.60+0.06 A N U S C R I P T Infection inhibition IC 50 SA [µM] -0.14+0.05 0.37+0.09 5.59+0.18 1.98+0.08 M</cell></row><row><cell cols="2">A C C E P T E D</cell></row><row><cell></cell><cell>29</cell></row></table><note><p><s>10 SA 0.40 1b treated virus at</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>The entire list of inhibition values of all</s></p></div></figDesc><table><row><cell>inhibitors are shown in Table S7. b) Binding inhibition of R18 labelled A/X31 virus to human</cell></row><row><cell>erythrocytes with the most potent inhibitors. Mean values (n≥3) were fitted with a four</cell></row></table><note><p><s>parametric logistic fit to obtain IC 50 values (Table2).Error bars: SEM.See Fig.S10andTable S7 for the IC 50 values of all inhibitors.</s><s>c, d) Microscale thermophoresis: Change in</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head>(PG MW SA DF )*</head><label></label><figDesc></figDesc><table><row><cell></cell><cell>KiHAI SA</cell><cell>KiHAI NP</cell><cell>Binding</cell><cell>Binding</cell><cell>Kdapp NP</cell></row><row><cell></cell><cell>[µM]</cell><cell>[nM]</cell><cell>inhibition</cell><cell>inhibition</cell><cell>[µM]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>IC 50 SA [mM]</cell><cell>IC 50 NP [µM]</cell><cell></cell></row><row><cell>α-methylsialoside</cell><cell>2000</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell>2800±300</cell></row><row><cell>α-2,6-sialyllactose</cell><cell>100000</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell>-</cell></row><row><cell>LPG 10 SA 0.40 1b</cell><cell>19.5±5.9</cell><cell>328±98</cell><cell>0.22+0.03</cell><cell>3.74+0.50</cell><cell>10.10±2.90</cell></row><row><cell>LPG 10 SA 0.70 1c</cell><cell>5.9±2.7</cell><cell>59±27</cell><cell>0.22+0.02</cell><cell>2.20+0.20</cell><cell>0.60±0.32</cell></row><row><cell>dPG 10 SA 0.15 2b</cell><cell>9.3±1.7</cell><cell>358±66</cell><cell>1.54+0.08</cell><cell>59.1+3.1</cell><cell>1.46±0.65</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>and 82.5±24.0</cell></row><row><cell>dPG 500 SA 0.20 3b</cell><cell>20.3±4.7</cell><cell>16±4</cell><cell>1.01+0.05</cell><cell>0.82+0.05</cell><cell>0.013±0.006</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>and 1.35±0.43</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_9"><head>Table 3</head><label>3</label><figDesc><div><p><s>Mean values (n≥3) of the half maximal inhibitory concentration (IC 50 ) of selected inhibitors after infection of MDCK-II cells at an MOI of 0.05 for 24 h.For infection inhibition experiments the SE of logIC 50 is given.For a list of all compounds see TableS8.</s></p></div></figDesc><table><row><cell>Compound</cell><cell>Infection inhibition</cell><cell>Infection inhibition</cell></row><row><cell>(PG MW SA DF )</cell><cell>IC 50 SA [µM]</cell><cell>IC 50 NP [nM]</cell></row><row><cell>LPG 10 1</cell><cell>-</cell><cell>500000.00</cell></row><row><cell>LPG 10 SA 0.40 1b</cell><cell>0.14+0.05</cell><cell>2.35+0.83</cell></row><row><cell>LPG 10 SA 0.70 1c</cell><cell>0.37+0.09</cell><cell>3.69+0.91</cell></row><row><cell>dPG 10 SA 0.15 2b</cell><cell>5.59+0.18</cell><cell>215.15+6.92</cell></row><row><cell>dPG 500 SA 0.20 3b</cell><cell>1.98+0.08</cell><cell>1.60+0.06</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_15"><head>Table S4 .</head><label>S4</label><figDesc><div><p><s>Yield and degree of functionalization (DF) of dPGOMs.</s></p></div></figDesc><table><row><cell>dPGOH</cell><cell></cell><cell></cell><cell>dPG 10 2</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>dPG 500 3</cell><cell></cell></row><row><cell>dPG-OMs, DF</cell><cell>0.05</cell><cell>0.15</cell><cell>0.31</cell><cell>0.64</cell><cell cols="2">0.90 0.05</cell><cell>0.19</cell><cell>0.38</cell><cell>0.70</cell></row><row><cell>Yield %</cell><cell>84</cell><cell>81</cell><cell>79</cell><cell>86</cell><cell>88</cell><cell>82</cell><cell>76</cell><cell>82</cell><cell>87</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_16"><head>Table S5 .</head><label>S5</label><figDesc><div><p><s>Yield and degree of functionalization of dPG-N 3.</s></p></div></figDesc><table><row><cell></cell><cell>ACCEPTED MANUSCRIPT</cell><cell></cell></row><row><cell cols="3">lyophilized to afford the pure 72.3 mg dPGSA 3 with a quantitative conversion</cell></row><row><cell cols="3">(determined by 1 H NMR). Yield= 82%. 1 H NMR (500 MHz, D 2 O): δ (ppm) = 7.96 (s, 1H,</cell></row><row><cell cols="3">C=CH), 4.60-3.39 [m, SA (H-8, NH, H-7, H-4, H-9, H-5, H-6); SCH 2 C=C; and nPG core],</cell></row><row><cell cols="3">2.80-2.77 (m, SA, H-3e), 2.02 (s, SA, NHAc), 1.81 (SA, H-3a), 1.36 (m, -CH 2-core),</cell></row><row><cell>dPGOH</cell><cell>dPG 10 2</cell><cell>dPG 500 3</cell></row><row><cell cols="3">dPGN 3 , DF Yield % Synthesis of dPGSAs 2a-2e and 3a-3d 0.05 0.15 0.31 88 85 89 dPGSA 2a dPG-N 3 with DF = 0.05 (0.07 g, 0.045 mmol N 3 groups) was dissolved in 4 mL of THF-0.64 0.90 0.05 0.19 0.38 0.70 87 86 80 78 80 84 H 2 O (1:1) solvent mixture followed by addition of solution of prop-2-ynyl α-thiosialoside (32.6 mg, 0.059 mmol, 1.3 eq. with respect to N 3 groups) in THF (1 mL). The M 0.88-0.87 (m, -CH 3 core). IR (film): ν = 3355, 2922, 2873, 1609, 1559, 1456, 1388, 1323, 1281, 1250, 1111, 1078, 954 cm −1 . Table S5 and S6 shows the yields, degree of functionalization, and molecular weight A N U S C R I P T determined by NMR/GPC of the final compounds dPGSA 2a-2e and 3a-3d.</cell></row><row><cell cols="3">CuSO 4 .5H 2 O (2.3 mg, 0.0092 mmol, 0.2 eq with respect to N 3 groups) was dissolved in 0.1 mL of H 2 O and added to the solution of sodium ascorbate (18.3 mg, 0.092 mmol, 2.0 eq with respect to N 3 groups) in 0.2 ml H 2 O. The resulting solution was added drop wise to the solution containing dPG-N 3 and prop-2-ynyl α-thiosialoside. The reaction mixture was degassed thoroughly with argon for 5 minutes and then allowed to stir for 3 days at room temperature under argon atmosphere. The progress of the reaction was monitored by IR. When the peak at ~2100cm -1 corresponding to azide stretching frequency completely disappeared, the solvent was evaporated at rotary evaporator. 2M NaOH (5 mL) was A C C E P T E D</cell></row><row><cell cols="3">added to the residue, and stirred at room temperature for 2 hours. The reaction mixture</cell></row><row><cell cols="3">was neutralized by adding 2M HCl solution and dialyzed first against water and aqueous</cell></row><row><cell cols="3">EDTA solution for 2 days and again using only water for 4 days. The solvent of the</cell></row><row><cell cols="3">dialysis was changed thrice a day. The aqueous solution obtained after dialysis was</cell></row><row><cell></cell><cell>67</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_17"><head>Table S5 .</head><label>S5</label><figDesc><div><p><s>Yield, DF, and molecular weight of dPGSAs 2a-2e.</s></p></div></figDesc><table><row><cell>dPGSA</cell><cell>2a</cell><cell>2b</cell><cell>2c</cell><cell>2d</cell><cell>2e*</cell></row><row><cell>DF</cell><cell>0.05</cell><cell>0.15</cell><cell>0.31</cell><cell>0.64</cell><cell>0.90</cell></row><row><cell>Yield %</cell><cell>82</cell><cell>87</cell><cell>81</cell><cell>90</cell><cell>92</cell></row><row><cell>M w (kDa)</cell><cell>15</cell><cell>23</cell><cell>32</cell><cell>55</cell><cell>59</cell></row><row><cell>(NMR)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>GPC (H 2 O)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>M n (kDa)</cell><cell>14.6</cell><cell>24.9</cell><cell>24.2</cell><cell>40.2</cell><cell>56.8</cell></row><row><cell>M w kDa)</cell><cell>28.9</cell><cell>35.2</cell><cell>42.1</cell><cell>52.6</cell><cell>86.5</cell></row><row><cell>PDI</cell><cell>2.0</cell><cell>1.4</cell><cell>1.7</cell><cell>1.3</cell><cell>1.5</cell></row><row><cell cols="6">*The compound 2e was prepared using dPG (M n = 7.2 kDa, M w = 10.4 kDa) and analyzed by</cell></row><row><cell>GPC-MALLS.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_18"><head>Table S6 .</head><label>S6</label><figDesc><div><p><s>Yields, DFs, and molecular weights of dPGSAs 3a-3d.</s></p></div></figDesc><table><row><cell>dPGSA</cell><cell>3a</cell><cell>3b</cell><cell>3c</cell><cell>3d</cell></row><row><cell>DF</cell><cell>0.05</cell><cell>0.19</cell><cell>0.38</cell><cell>0.70</cell></row><row><cell>Yield %</cell><cell>81</cell><cell>72</cell><cell>78</cell><cell>74</cell></row><row><cell>Mw</cell><cell>621</cell><cell>960</cell><cell>1440</cell><cell>2103</cell></row><row><cell>(kDa)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>(NMR)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_19"><head>Table S7 .</head><label>S7</label><figDesc><div><p><s>Virus binding inhibition experiments.</s><s>Inhibition values (KiHAI) from the hemagglutination inhibition assay and the single erythrocyte binding inhibition assay (IC 50 ) complementing data shown in Table 2. Values are expressed in terms of sialic acid and nanoparticle concentration.</s><s>For binding inhibition experiments the SE of logIC 50 is given.</s></p></div></figDesc><table><row><cell>Compound (SA%, scaffold)</cell><cell>KiHAI Sialic acid [µM]</cell><cell cols="3">KiHAI Nanoparticle [nM] M A N U S C R I P T Binding inhibition IC 50SA [mM] Binding inhibition IC 50NP [µM]</cell></row><row><cell cols="3">LPG 10 1 LPG 10 SA 0.10 1a LPG 10 SA 1.00 1d LPG 10 SA 0.2 1e dPG 10 2 dPG 10 SA 0.05 2a dPG 10 SA 0.30 2c dPG 10 SA 0.65 2d dPG 10 SA 0.90 2e dPG 500 3 dPG 500 SA 0.05 3a A C C E P T E D -2000.0* 1000.0±0.0 1860.0±620.0 68888.9±22963.0 2000000.0* 139860.0* 7407.4±0.0 -2000000.0* 2000.0* 250000.0* 62.5±0.0 1225.5±0.0 57.3±21.6 540.5±203.8 25000.0±0.0 206612.6±0.0 -2000000.0* 2000.0* 5587.00*</cell><cell>-2.30+0.05 1.00* 4.00* -2.53+0.15 1.93+0.05 1.02+0.17 n.d. -n.d.</cell><cell>4000.00* 164.14+3.57 7.41* 148.15* 4000.00* 316.13+18.75 37.75+0.98 9.65+1.60 n.d. 4000.00* n.d.</cell></row><row><cell>dPG 500 SA 0.40 3c</cell><cell>666.7±166.7</cell><cell>269.9±67.5</cell><cell>3.42+0.03</cell><cell>1.39+0.01</cell></row><row><cell>dPG 500 SA 0.70 3d</cell><cell>50000±0.0</cell><cell>10989±0.0</cell><cell>n.d.</cell><cell>n.d.</cell></row></table><note><p><s>Maximum concentration tested without an inhibitory effect is indicated by (*).</s><s>n.d.</s><s>= not determined.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_20"><head>Table S8 .</head><label>S8</label><figDesc><div><p><s>IC 50 values from cell viability based infection inhibition experiments.</s><s>IC 50 values are presented either in terms of the sialic acid or nanoparticle concentration indicated by SA or NP respectively.</s><s>In addition, the IC 50NP is also expressed in terms of its corresponding mass.</s><s>n.d= not determined.</s><s>No detectable inhibition within the tested concentration range is indicated by (*).</s><s>For infection inhibition experiments the SE of logIC 50 is given.</s><s>This table complements</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_21"><head>Table 3 .</head><label>3</label><figDesc></figDesc><table><row><cell>Compound (PG MW SA Df )</cell><cell>Infection inhibition IC 50SA [µM]</cell><cell>Infection inhibition IC 50NP [nM]</cell></row><row><cell>LPG 10 SA 0.10 1a</cell><cell>43.16+0.12</cell><cell>3.08+8.57</cell></row><row><cell>LPG 10 SA 1.00 1d</cell><cell>16.15+0.74</cell><cell>119.63+5.48</cell></row><row><cell>LPG 10 SA 0.2 1e</cell><cell>4.85+0.22</cell><cell>179.44+0.22</cell></row><row><cell>dPG 10 2</cell><cell>-</cell><cell>10000.00</cell></row><row><cell>dPG 10 SA 0.05 2a</cell><cell>500.00*</cell><cell>62.50*</cell></row><row><cell>dPG 10 SA 0.30 2c</cell><cell>1.84+0.06</cell><cell>36.14+1.17</cell></row><row><cell>dPG 10 SA 0.65 2d</cell><cell>1.86+0.29</cell><cell>15.40+2.74</cell></row><row><cell>dPG 10 SA 0.90 2e</cell><cell>n.d.</cell><cell>n.d.</cell></row><row><cell>dPG 500 3</cell><cell>-</cell><cell>500000.00*</cell></row><row><cell>dPG 500 SA 0.05 3a</cell><cell>500.00*</cell><cell>1.40*</cell></row><row><cell>dPG 500 SA 0.40 3c</cell><cell>1.07+0.15</cell><cell>0.43+0.06</cell></row><row><cell>dPG 500 SA 0.70 3d</cell><cell>n.d.</cell><cell>n.d.</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Andreas Herrmann: h1211dyz@rz.hu-berlin.de</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="1">H NMR (500 MHz, CD 3 OD) of LPGSA protected (DF=0.10). 1 H NMR (500 MHz, D 2 O) of LPG-OMs. LPGSA protected , DF = 0.10 LPG-OMs, DF = 0.20</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="1">H NMR (500 MHz, D 2 O) of LPGN 3 , DF=0.20. 1 H NMR (500 MHz, D 2 O), of dPG 10 OMs, DF=0.05. LPG-N 3 , DF=0.20 dPGOMs, DF=0.05</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="1">H NMR (500 MHz, D 2 O) of dPG 10 N 3 , DF=0.05. 1 H NMR spectra of the representative compounds from LPGSAs, dPGSAs.1 H NMR (500 MHz, D 2 O) of LPGSA 1b, DF=0.4. dPGN 3 , DF = 0.05 LPGSA 1b</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We thank Dirk Steinhilber for providing us the linear polyglycerol precursor and Professor Dr. Joachim Heberle for giving us the opportunity to perform MST measurements in his lab.</s></p><p><s>Further, we are grateful for financial support within the SFB765 by the German Science Foundation (DFG) and the Focus Area Nanoscale of the Freie Universität Berlin.</s><s>We acknowledge Dr. Pamela Winchester for careful language polishing of the manuscript.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head><p><s>Synthetic procedures, characterization data, 1 HNMR spectra, additional figures from DLS, Cryo-TEM, cell viability, FACS, MST, infection assay, and in vivo, and details on statistical mechanical model are available online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Linear polysialoside outperforms dendritic analogs for inhibition of influenza virus infection in vitro and in vivo</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Emerging antiviral strategies to interfere with influenza virus entry</title>
		<author>
			<persName><forename type="first">E</forename><surname>Vanderlinden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Naesens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Res Rev</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="301" to="339" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">G</forename><surname>Barr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Garten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gregory</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">D</forename><surname>Gust</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Hampson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Hay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Hurt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Kelso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Klimov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kageyama</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Komadina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Lapedes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mosterin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Obuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D M</forename><surname>Odagiri</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Osterhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Rimmelzwaan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Skepner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stohr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Tashiro</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The global circulation of seasonal influenza A (H3N2) viruses</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Fouchier</surname></persName>
		</author>
		<author>
			<persName><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">320</biblScope>
			<biblScope unit="issue">5874</biblScope>
			<biblScope unit="page" from="340" to="346" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Lapedes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Bestebroer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Rimmelzwaan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D M</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Mapping the antigenic and genetic evolution of influenza virus</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A M</forename><surname>Osterhaus</surname></persName>
		</author>
		<author>
			<persName><surname>Fouchier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="issue">5682</biblScope>
			<biblScope unit="page" from="371" to="376" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Medical management of influenza infection</title>
		<author>
			<persName><forename type="first">A</forename><surname>Moscona</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Med</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="397" to="413" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Skehel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Wiley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Biochem</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="531" to="569" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Ekiert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bhabha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M.-A</forename><surname>Elsliger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M.-A</forename><surname>Friesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H E</forename><surname>Jongeneelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Antibody recognition of a highly conserved influenza virus epitope</title>
		<author>
			<persName><forename type="first">J</forename><surname>Throsby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Goudsmit</surname></persName>
		</author>
		<author>
			<persName><surname>Wilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">324</biblScope>
			<biblScope unit="issue">5924</biblScope>
			<biblScope unit="page" from="246" to="251" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Joyce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Wheatley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">V</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">Y</forename><surname>Chuang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Soto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Bailer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Druz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Georgiev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Gillespie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kanekiyo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Kong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Leung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Narpala</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Prabhakaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Asokan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Boyington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bylund</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Darko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lees</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Ransier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Whittle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Yassine</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Y</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Matsuoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Tsybovsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C S</forename><surname>Baxa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Program</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mullikin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Subbarao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Douek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Graham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Koup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ledgerwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Roederer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Shapiro</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Kwong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Mascola</surname></persName>
		</author>
		<author>
			<persName><surname>Mcdermott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="609" to="623" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Polyacrylamides bearing pendant a-sialoside groups strongly inhibit agglutination of erythrocytes by influenza A Virus: multivalency and steric stabilization of particulate biological system</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Lees</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Spaltenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Kingery-Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Whitesides</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Chem</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="3419" to="3433" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mammen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Whitesides</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angew Chem Int Ed</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="2775" to="2794" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Polyacrylamides bearing pendant R-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus: the strong inhibition reflects enhanced binding through cooperative polyvalent interactions</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Sigal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mammen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dahmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Whitesides</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="3789" to="3800" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Generation and in situ evaluation of libraries of poly(acrylic acid) presenting sialosides as side chains as polyvalent inhibitors of influenzamediated hemagglutination</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mammen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Whitesides</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="4103" to="4111" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><surname>Fasting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Schalley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Seitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Koksch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dernedde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Multivalency as a chemical organization and action principle</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Graf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Knapp</surname></persName>
		</author>
		<author>
			<persName><surname>Haag</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angew Chem Int Ed Engl</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">42</biblScope>
			<biblScope unit="page" from="10472" to="10498" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Reuter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Myc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Hayes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Gan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Qin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">T</forename><surname>Piehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Inhibition of viral adhesion and infection by sialicacid-conjugated dendritic polymers</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Esfand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Tomalia</surname></persName>
		</author>
		<author>
			<persName><surname>Baker</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioconjug Chem</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="271" to="278" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">The effect of acrylamide on human polymorphonuclear neutrophils in vitro</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mangan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Snyder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Ind Med</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="305" to="311" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Gambaryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Tuzikov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">V</forename><surname>Bovin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Matrosovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Chinarev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Polymeric inhibitor of influenza virus attachment protects mice from experimental influenza infection</title>
		<author>
			<persName><surname>Juneja</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antiviral Research</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="201" to="205" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Landers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">T</forename><surname>Piehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Myc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Myc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hamouda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Prevention of influenza pneumonitis by sialic acid-conjugated dendritic polymers</title>
		<author>
			<persName><forename type="first">Andrzej</forename><forename type="middle">T</forename><surname>Galecki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Jeffrey</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Landers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">L</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">T</forename><surname>Piehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Myc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Myc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hamouda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Galecki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R J</forename><surname>Baker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Inf Dis</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1222" to="1230" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Pathogen inhibition by multivalent ligand architectures</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bhatia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Camacho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Haag</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="issue">28</biblScope>
			<biblScope unit="page" from="8654" to="8666" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Nanostructured glycan architecture is important in the inhibition of influenza A virus infection</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Na</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Kwak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Douaisi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Youn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Kane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Dordick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Linhardt</surname></persName>
		</author>
		<idno type="DOI">10.1038/NNANO.2016.181</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Nanotechnol</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Polymer therapeutics: concepts and applications</title>
		<author>
			<persName><forename type="first">R</forename><surname>Haag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kratz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angew Chem Int Ed Engl</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1198" to="1215" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution</title>
		<author>
			<persName><forename type="first">M</forename><surname>Imran Ul-Haq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chapanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Kizhakkedathu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomaterials</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">35</biblScope>
			<biblScope unit="page" from="9135" to="9147" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Beyond poly(ethylene glycol): linear polyglycerol as a multifunctional polyether for biomedical and pharmaceutical applications</title>
		<author>
			<persName><forename type="first">A</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Müller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Frey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomacromolecules</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1935" to="1954" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Dendritic polyglycerols for biomedical applications</title>
		<author>
			<persName><forename type="first">M</forename><surname>Calderon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Quadir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Haag</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Mater</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="190" to="218" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mammen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dahmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Whitesides</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Chem</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="4179" to="4190" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Vonnemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Liese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kuehne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dernedde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bottcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Netz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Size dependence of steric shielding and multivalency effects for globular binding inhibitors</title>
		<author>
			<persName><surname>Haag</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="2572" to="2579" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Solvent-assisted anionic ring opening polymerization of glycidol: toward medium and high molecular weight hyperbranched polyglycerols</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ul-Haq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Shenoi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Kizhakkedathu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Polymer Science Part A: Polymer Chemistry</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2614" to="2621" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Hyperbranched polyglycerol as a colloid in cold organ preservation solutions</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Chafeeva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Nguan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Kizhakkedathu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Du</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e0116595</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Relation of virus particle counts to the hemagglutinating activity of influenza virus suspensions measured by the HA pattern test and by use of the photometric HCU method</title>
		<author>
			<persName><forename type="first">U</forename><surname>Desselberger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Virol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="365" to="372" />
			<date type="published" when="1975">1975</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Hemagglutination inhibition assays</title>
		<author>
			<persName><forename type="first">G</forename><surname>Cross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Seminars in Avian and Exotic Pet Medicine</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="15" to="18" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">I</forename><surname>Papp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sieben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Sisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kostka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Böttcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Herrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Inhibition of influenza virus activity by multivalent glycoarchitectures with matched sizes</title>
		<author>
			<persName><surname>Haag</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ChemBioChem</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="887" to="895" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Kenngott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Schroter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kuhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jennrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Watzlawick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">T</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wolff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Norley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Scheffold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Stumhofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Saris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Schwab</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Timed action of IL-27 protects from immunopathology while preserving defense in influenza</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Hunter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Debes</surname></persName>
		</author>
		<author>
			<persName><surname>Hamann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Pathog</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e1004110</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Synthesis of linear high molar mass glycidol-based polymers by monomer-activated anionic polymerization</title>
		<author>
			<persName><forename type="first">M</forename><surname>Gervais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A.-L</forename><surname>Brocas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cendejas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Deffieux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carlotti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1778" to="1784" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Hyperbranched polyglycerols by ring-opening multibranching polymerization</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sunder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Frey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Muelhaupt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromol Symp</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="187" to="196" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">An approach to glycerol dendrimers and pseudodendritic polyglycerols</title>
		<author>
			<persName><forename type="first">R</forename><surname>Haag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sunder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-F</forename><surname>Stumbe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2954" to="2955" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Electron Microscopy of the Influenza virus submembranal structure</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W H</forename><surname>Ruigrok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Calder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Wharton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virology</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="311" to="316" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Characterization of Three Highly Purified Influenza Virus Strains by Electron Microscopy</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Andree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A M H</forename><surname>Huysduynen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Mellema</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J.Gen. Virol</title>
		<imprint>
			<biblScope unit="page" from="799" to="802" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Sauter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Glick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Crowther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Eisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Skehel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J.R</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Crystallographic detection of a second ligand binding site in influenza virus hemagglutinin</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Knowles</surname></persName>
		</author>
		<author>
			<persName><surname>Wiley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="324" to="328" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Monomeric inhibitors of influenza neuraminidase enhance the hemagglutination inhibition activities of polyacrylamides presenting multiple C-sialoside groups</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mammen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Whitesides</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chemistry and Biology</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="97" to="104" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Sauter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Bednarski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Wurzburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hamon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Whitesides</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Skehel</surname></persName>
		</author>
		<author>
			<persName><surname>Wiley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="8388" to="8396" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Galabov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Simeonova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gegova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antivi Chem and Chemother</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="251" to="258" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Anselmo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Vogus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Menegatti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Helgeson</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Elasticity of Nanoparticles Influences Their Blood Circulation, Phagocytosis, Endocytosis, and Targeting</title>
		<author>
			<persName><surname>Mitragotri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACS Nano</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="3169" to="3177" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Physical approaches to biomaterial design</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mitragotri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lahann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Materials</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="15" to="23" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">On the nature of the multivalency effect: a thermodynamic model</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">I</forename><surname>Kitov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Bundle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">52</biblScope>
			<biblScope unit="page" from="16271" to="16284" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">A general theory of DNAmediated and other valence-limited colloidal interactions</title>
		<author>
			<persName><forename type="first">P</forename><surname>Varilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Angioletti-Uberti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Mognetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Frenkel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Chem Phys</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">94108</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid</title>
		<author>
			<persName><forename type="first">W</forename><surname>Weis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cusack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Paulson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Skehel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Wiley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Synthesis of linear high molar mass glycidol-based polymers by monomer-activated anionic polymerization</title>
		<author>
			<persName><forename type="first">M</forename><surname>Gervais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A.-L</forename><surname>Brocas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cendejas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Deffieux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carlotti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1778" to="1784" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Hyperbranched polyglycerols by ring-opening multibranching polymerization</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sunder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Frey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Muelhaupt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromol Symp</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="187" to="196" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">An approach to glycerol dendrimers and pseudodendritic polyglycerols</title>
		<author>
			<persName><forename type="first">R</forename><surname>Haag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sunder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-F</forename><surname>Stumbe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2954" to="2955" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Solvent-assisted anionic ring opening polymerization of glycidol: toward medium and high molecular weight hyperbranched polyglycerols</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ul-Haq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Shenoi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Kizhakkedathu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Polymer Science Part A: Polymer Chemistry</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2614" to="2621" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Sialoside clusters as potential ligands for siglecs (sialoadhesins)</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Gan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Roy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canadian Journal of Chemistry</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="908" to="916" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Shitori, syntheses of 2-O-glycosyl derivatives of Nacetyl-D-neuraminic acid</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ogura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Furuhata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Carbohydr. Res</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="37" to="51" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Vonnemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Liese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kuehne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dernedde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bottcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Netz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Size dependence of steric shielding and multivalency effects for globular binding inhibitors</title>
		<author>
			<persName><surname>Haag</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="2572" to="2579" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">A general theory of DNAmediated and other valence-limited colloidal interactions</title>
		<author>
			<persName><forename type="first">P</forename><surname>Varilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Angioletti-Uberti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Mognetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Frenkel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Chem Phys</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">94108</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Communication: a simple analytical formula for the free energy of ligand-receptor-mediated interactions</title>
		<author>
			<persName><forename type="first">S</forename><surname>Angioletti-Uberti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Varilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Mognetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Tkachenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Frenkel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Chem Phys</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">21102</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">On the nature of the multivalency effect: a thermodynamic model</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">I</forename><surname>Kitov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Bundle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">52</biblScope>
			<biblScope unit="page" from="16271" to="16284" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
